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ABSTRACT 
 
Carbohydrate (CHO) ingestion, especially a high glycemic index (GI) CHO meal can 
improve sleep in healthy individuals, but evidence is lacking regarding its efficacy to 
improve the poor sleep quality inherent in insomnia.  The efficacy of a high GI meal to 
improve sleep lies in its capacity to increase the availability of tryptophan (TRP), the 
amino acid precursor to serotonin (5HT), which is an intermediary product to 
melatonin, a primary neurohormone that influences sleep initiation.  The addition of fat 
or protein to a CHO meal lowers the glycemic response.  Thus, the effects of the GI of 
mixed macronutrient meals on sleep remain unknown.  This thesis: (1) investigated the 
effects of a mixed macronutrient high GI (MHGI) and low GI (MLGI) meal compared 
to a carbohydrate only high GI (CHGI) meal on the postprandial availability of TRP to 
the brain, measured by it concentration relative to other large neutral amino acids 
(TRP/LNAA); and (2) evaluated the efficacy of a high GI mixed macronutrient meal to 
improve subjective sleep and objective sleep measures using polysomnography (PSG) 
in a group of men and women with insomnia. 
 
A meta-analysis of the mean data on 9 PSG sleep variables commonly affected by the 
first night effect (FNE) was completed (Chapter 4); the potential moderating factors 
included the sleep setting (laboratory, home), recording montage (full PSG, 
EEG/EMG/EOG only, switched PSG; full PSG night 1 followed by EEG/EMG/EOG 
only on night 2), sleep period (ad libitum, fixed, unknown), and the age of the study 
population.  A total of 24 studies were included in the meta-analysis reporting on 421 
healthy sleepers.  The data confirm the FNE in healthy sleepers and further describe the 
FNE by a prolonged SOL (4.46 min), delayed REML (20.55 min), an increase in 
 xiv 
WASO (3.88%), and reductions in REMS (-2.17%), TST (-18.81 min), and SE (-
4.66%; all p < 0.01).  There was a two-fold increase in the delayed REML during 
laboratory compared to home based PSG (22.73 vs. 11.36 min, respectively, both p < 
0.01). 
 
The postprandial glucose and insulin responses to a high and low GI mixed 
macronutrient meal were compared to a CHO only meal on plasma TRP/LNAA 
concentration in healthy volunteers after an overnight fast (Chapter 5).  The study was a 
repeated measures design where 10 healthy college-aged males underwent GI testing 
with additional blood collection to profile the 4 h postprandial amino acid responses to 
three test meals administered in a random order; carbohydrate only high GI (CHGI), an 
isoenergetic mixed macronutrient high and low GI meal (MHGI and MLGI, 
respectively).  The energy from the mixed macronutrient meals (MHGI, MLGI) was 
nearly half that of the CHGI meal (~1915 vs. 3212 kJ, respectively) and the metabolic 
responses were improved (i.e., lower GI/GL, lower insulin release).  There was a 
significant postprandial rise in plasma TRP/LNAA levels after all meals with a peak 
between 2-3 h (p < 0.05); the percentage rise from baseline was greatest after the CHGI 
meal (23%), followed by the MHGI (17%), and the MLGI meals (8%); the TRP/LNAA 
response was greater after CHGI compared to MLGI (p = 0.04) indicated by their 
respective total area under the curve (AUC). 
 
 
 
 
 
 xv 
The efficacy of the MHGI meal compared to the MLGI meal to improve subjective and 
PSG measures of sleep quality in men and women with insomnia was investigated in 
the final study (Chapter 6).  The study was a repeated measure, cross-over design (n = 
8, 4 men, 4 women) where participants underwent testing on 2 consecutive nights.  
Meals were given 3 h prior to individual habitual bedtimes.  Subjective ratings of 
palatability, satiety, and sleepiness were assessed after each meal by a 10 cm visual 
analogue scale.  Subjective measures of post-sleep quality were assessed using a 5-
point Likert scale and the level of sleepiness post-study was assessed by a 10 cm visual 
analogue scale.  Postprandial measures of TRP/LNAA and 5HT concentrations were 
assessed at baseline prior to meal consumption and for 3 h until bedtime.  The average 
energetic load (kJ/kg) was greater for women (33.0 ± 4.1) than men (25.4 ± 3.8, p = 
0.03).  Participants were self-reportedly more rested after the MHGI (2.8 cm) compared 
to the MLGI meal (2.2 cm; p = 0.01) corresponding to “average” and “somewhat”, 
respectively; this was clearly evident in women but not men.  There were no significant 
differences between the MHGI or MLGI meals on averaged 2-night PSG sleep 
variables.  Sex differences were present.  The SOL tended to be shorter in women 
compared to men on all testing nights; PSG SOL values were lower than subjective 
SOL values.  Men had more EEG arousals (AI) than women after the MHGI (p < 
0.001) and MLGI meal (p < 0.05).  Light sleep (NREM1) tended to be greater in men 
than women, especially after the MLGI meal.  Both meals elicited a postprandial rise 
plasma TRP/LNAA levels; the percentage peak rise from baseline after the MHGI meal 
(17%) was 3.5 fold greater than after the MLGI (8%) meal despite marginal statistical 
significance; the AUC after the MHGI (1.73 ± 1.3) meal was also not statistically larger 
than after the MLGI (0.50 ± 0.46; p = 0.12) meal.  There was no significant 
postprandial change in PPP-5HT concentrations. 
 xvi 
The findings in the final study indicate the MHGI meal improves subjective sleep 
quality when provided as a regular evening meal 3 h prior to bedtime but only to 
women with insomnia.  The PSG data demonstrated significant night-to-night 
variability in sleep quality in both men and women.  This corroborates findings in the 
meta-analysis (Chapter 4).  Remarkably, the postprandial increase in plasma 
TRP/LNAA concentration after the mixed macronutrient meal was identical in healthy 
participants (Chapter 5) and in the participants with insomnia (Chapter 6).  However, 
despite an elevated TRP/LNAA response, especially after the MHGI meal, platelet poor 
plasma (PPP) 5HT concentration was not changed.  The observed changes in blood 
glucose and insulin indicate the postprandial plasma TRP/LNAA response is likely 
mediated by the GL of a mixed macronutrient meal.  Further studies are needed to 
evaluate a range of GL values from mixed macronutrient meals on the postprandial 
plasma TRP/LNAA concentration.  Further studies are required to confirm the 
mechanisms underpinning related to improvements to sleep after high GI mixed 
macronutrient meals.   
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CHAPTER 1:  Introduction 
 
Insomnia represents one of the most commonly diagnosed sleep disorders in many 
western societies and is characterised by “the subjective dissatisfaction with the 
quantity, quality, and/or timing of sleep that occurs at least three times per week, for at 
least 1 month” while chronic insomnia refers to complaints occurring for at least three 
months (Morin and Espie 2003).  Acute periods of sleeplessness often lead to daytime 
cognitive impairments and fatigue, whereas chronic insomnia impacts negatively on the 
quality of life including determinants of physical and social functioning, mental health, 
vitality, and pain (Hatoum, Kong et al. 1998; Katz and McHorney 2002).  Higher 
absenteeism, impaired job performance, and increased health care utilisation contribute 
to the financial and economical burdens of insomnia in Australian and the USA 
(Hillman, Fanzca et al. 2006; Daley, Morin et al. 2009). 
 
In Australia, the prevalence of insomnia is reportedly between 13-20% in a group of 
adults aged 21 years and over (Lack, Miller et al. 1988), however in a separate study 
17% of Australian men and 25% of women reported difficulty sleeping in a community 
based sample (Olson 1996).  The characteristic sleep pattern inherent in insomnia is 
fragile as there is considerable night-to-night variability (Vallieres, Ivers et al. 2005).  
On many nights of the week, pervasive, maladaptive cognitive thoughts and behaviours 
limit the total sleep duration.  On other nights, sleep quality closely resembles a normal 
pattern or can be longer in duration due to the sleep homeostatic drive.  Moreover, 
sleeping too little (<6 h) or too much (>9 h) is a significant risk factor for weight gain, 
insulin resistance, and type 2 diabetes (Taheri, Lin et al. 2004), and is associated with 
increased mortality (Knutson and Turek 2006).   
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Primary treatment for insomnia includes pharmacotherapy and behavioural treatment in 
the form of cognitive behavioural therapy (CBT).  In the short term, pharmacotherapy 
(i.e., benzodiazepines, nonbenzodiazepines, and serotonin (5HT) agonists) can be 
highly effective to promote sleep onset or increase the total sleep time (Nowell, 
Mazumdar et al. 1997).  However, these medications can be highly addictive and are 
associated with significant, negative, side-effects including persistent daytime 
drowsiness, cognitive impairment, and even fatal driving accidents (Berlin, Warot et al. 
1993; Sateia and Nowell 2004; Gustavsen, Brarnness et al. 2008).  CBT, as an adjunct 
to pharmacotherapy or delivered as a monotherapy, is highly efficacious in the 
management of insomnia symptoms since the aim is to prevent conditioned cognitive 
and behavioural patterns and thought from perpetuating insomnia (Morin and Espie 
2003).  However, CBT requires trained clinicians, is usually time-consuming (≥12 
weeks) and is associated with high drop-out rates (Ong, Kuo et al. 2008).  Despite the 
effectiveness of primary insomnia treatment, over 1.6 million adults in the USA use 
forms of complementary and alterative medicine (CAM) therapies as a self-directed 
treatment option for insomnia (Pearson, Johnson et al. 2006).  CAM therapies include 
standardised psychological programs that can be worked on independently at home 
(van Straten, Cuijpers et al. 2009), biofeedback, prescribed exercise, relation 
techniques, and herbal or dietary products marketed to facilitate sleep (Morin, LeBlanc 
et al. 2006).   
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Recently, a link between the glycemic index (GI) and sleep initiation in healthy sleepers 
was established, but evidence is lacking regarding the effectiveness in those with sleep 
difficulties.  Afaghi et al. (2007) showed that a high GI carbohydrate (CHO) compared 
to a low GI CHO meal given 4 h prior to bedtime shortened the time required to fall 
asleep by 50% (Afaghi, O'Connor et al. 2007).  These findings are limited in 
application given the meals were large (~3200kJ) and primarily CHO (90% total 
energy) and therefore not representative of a typical evening meal.  Also, the 
approximate GI (117) value corresponds to a glycemic load ( GL 175) nearly 1.5 times 
higher than most persons consume for an entire day (GL 120) (Brand-Miller).  As such 
these meals carry potentially significant unwanted metabolic responses, which make 
them unsuitable for everyday use, especially in those who are overweight or at risk for 
obesity or diabetes (Jenkins, Kendall et al. 2000; Pawlak, Ebbeling et al. 2002; Livesey 
2005). 
 
Whilst a lower energy meal may lower the glycemic response to the meal, it remains 
largely unknown to what extent the addition of fat and protein to this type of CHO meal 
will impact on changes to sleep behaviour and to what extent the GI may be used for 
the management of insomnia. 
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Thesis aims 
The thesis aimed to evaluate the efficacy of a high GI mixed macronutrient meal to 
improve sleep quality in insomnia.  In undertaking the study, the meal was analysed for 
its biochemical by-products that underpin the neurochemical regulation of sleep.  The 
following specific aims described the project in more detail: 
 
1. To develop a palatable, high and low GI version of a mixed macronutrient meal 
that was identical in appearance and suitable for daily use; 
2. To quantify the postprandial glucose, insulin, and amino acid responses; and 
3. To determine the efficacy of the high GI compared to the low GI mixed 
macronutrient meal to improve sleep quality. 
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Hypotheses 
1. The high GI compared to the low GI mixed macronutrient meal would show a 
greater postprandial rise in plasma TRP/LNAA concentration. 
2. The high GI compared to the low GI mixed macronutrient meal would result in 
better subjective sleep ratings for perceived sleep onset latency and sleep quality 
in participants with insomnia. 
3. The high GI compared to the low GI mixed macronutrient meal would decrease 
the sleep onset latency and increase sleep efficiency measured objectively using 
polysomnography (PSG) in participants with insomnia. 
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Significance 
Insomnia is a highly prevalent sleep disorder that often goes unrecognised and 
untreated despite significant adverse health outcomes (Benca, Obermeyer et al. 1992).  
This study represents a simple, cost-effective dietary manipulation of the GI of evening 
meals that could be employed as CAM therapy to manage acute or chronic insomnia.  
The results will provide empirical data on the effects of the GI on sleep in a mixed 
gender cohort with insomnia and will provide evidence for the biochemical mechanism 
underpinning the efficacy of high GI foods to promote sleep.  Moreover, the application 
of the findings to primary healthcare are evident given sleep hygiene education, which 
includes awareness of dietary practices, is often included with other forms of 
psychological and behavioural treatment, but is currently not recommended as a single 
therapy due to insufficient evidence to assess the effectiveness (Morgenthaler, Kramer 
et al. 2006) 
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Thesis outline 
 
Chapter 2 reviews the literature on the neurochemical regulation of sleep and the 
effects of dietary intake on sleep, highlighting the factors and biochemical by-products 
that influence postprandial sleepiness. 
 
Chapter 3 provides specific descriptions of the protocols and related concepts used in 
the meal design (e.g. GI testing) and those related to PSG (e.g., sleep testing).   
 
Chapter 4 reports a meta-analysis on the first night effect (FNE) describing the sleep 
quality on the first night during PSG compared to subsequent nights.  This study was 
completed to aid in the design of the final sleep study.   
 
Chapter 5 reflects the meal design and evaluation of the effects of isoenergetic high and 
low GI mixed macronutrient meals on postprandial blood glucose, insulin, and amino 
acid concentrations in healthy individuals.   
 
Chapter 6 reports the findings on the effects of the high GI compared to the low GI 
mixed macronutrient meal on subjective and objective measures of sleep in a 
participant group of men and women with insomnia.   
 
Chapter 7 provides a conclusion and the limitations of the thesis and recommendations 
for future dietary related sleep investigations. 
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CHAPTER 2: Literature Review 
 
Parts of the work presented in this section have been submitted for publication as 
follows: 
 
C.M. Chow & C.P. Herrera (2010). Feeding and Sleep Behavior.  In press: 
International Handbook of Behavior, Diet, and Nutrition.  New York, Springer 
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Introduction 
Conceptually, sleep was once thought to be a period of constant inactivity.  It is now 
known that sleep is a dynamic behaviour characterised by the cyclic pattern of non-
rapid eye movement sleep (NREMS) and rapid eye movement sleep (REMS).  This 
pattern of behaviour in humans is associated with specific central and peripheral 
nervous system activity that promotes protein synthesis to restore tissues and allows 
brain metabolic restoration (Oswald and Corner 1980; Adam and Oswald 1983).  Sleep 
is tightly regulated by a homeostatic process and a circadian process (Borbely and 
Achermann 1999).  The homeostatic drive for sleep is increased with prior 
wakefulness, whereas sleep-wake timing is under the influence of the master circadian 
clock located in the supra-chiasmatic nucleus (SCN) (Moore and Silver 1998).   
 
The neurochemical regulation of sleep reflects the activities in many neuronal regions.  
In fact, sleep becomes continuous and waking does not exist without the ascending 
reticular activating system (Moruzzi 1964).  The neural pathways extending both to and 
from this region, especially those in and around the hypothalamus are crucial for the 
regulation of sleep-wake states (Saper, Chou et al. 2001).  Transitions from sleep-wake 
states therefore reflect the reciprocal interaction of neuropeptides, steroids, and 
neurotransmitters along the hypothalamaic-pituitary-somatotrophic (HPS) and the 
hypothalamaic-pituitary-adrenocortical (HPA) systems in the brain (Steiger 2007).  
Indeed, chronic insomnia is associated with hyperactivation of the HPA axis (Vgontzas, 
Bixler et al. 2001).  Moreover, the lack of sleep exerts a modulating mechanism on 
endocrine function (Spiegel, Leproult et al. 1999), carbohydrate feeding behaviour 
(Wurtman and Wurtman 1995), and glucose metabolism (Knutson, Spiegel et al. 2007).   
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The relationship between sleeping and feeding is unique, as the behaviours are 
mutually exclusive, but demonstrate a reciprocal impact on human functioning. 
Sleeping and feeding are two crucial human behaviours necessary for survival since the 
absence of either will result in eventual death.  The main dietary constituents that can 
readily influence sleep are the macronutrients of carbohydrates (CHO) and fat with 
opposing effects from protein.  Whilst sleepiness is increased after CHO- or fat-based 
meals, macronutrient ingestion per se does not promote sleepiness.  Postprandial 
sleepiness is primarily influenced by circadian timing (time of day) of the meals and the 
macronutrient content via neurochemical changes.  Secondary factors include patterns 
of habitual feeding and gender.  Because feeding can alter sleep patterns, it will become 
vital for dieticians, nutritionists, and other allied health practitioners to understand the 
acute effects of diet on sleep patterns, since poor sleep (seen in shift workers and in 
those with insomnia and depression) has implications for poor health outcomes.  Figure 
2.1 depicts the factors influencing postprandial sleepiness; the most significant factors 
are those at the base levels of the pyramid.   
 
Figure 2.1.  Factors 
influencing postprandial 
sleepiness. 
The factors influencing 
postprandial sleepiness are 
presented on the pyramid. The 
most significant factors are 
those at the base levels of the 
pyramid. Note it is possible 
that these factors may interact 
with each other at any level. 
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Neuropeptides, steroids, and sleep 
Growth hormone-releasing hormone (GHRH) and corticotrophin-releasing hormone 
(CRH) play a major role in the HPS and HPA systems respectively. The neuropeptides 
and steroids known to exert specific effects on the sleep EEG include various peptides 
(GH, ghrelin, galanin, and neuropeptide Y) that promote sleep and others (CRH, 
somatostatin) that promote wakefulness (Steiger 2007).   
 
Increased levels of neuropeptide Y act as a signal for sleep onset, especially in males 
(Antonijevic, Murck et al. 2000).  Neuropeptide Y is though to represent a signal for 
sleep onset through antagonism of CRH (Steiger and Holsboer 1997).  GHRH release 
predominates in the first half of the night stimulating the appearance of growth 
hormone (GH) and slow wave sleep (Steiger 2007).  GH follows a circadian rhythm 
and can be stimulated by hypoglycaemia, stress, exercise, and protein depletion, but its 
release is inhibited by obesity, increased free fatty acids (FFA), and glucocorticoids 
(Merimee and Rabin 1973).  There is a positive relationship between the presence of 
ghrelin and GH (Weikel, Wichniak et al. 2003) suggesting that ghrelin also promotes 
slow wave sleep.  The neuropeptide galanin is involved in the regulation of NREM 
sleep via interactions with specific neurotransmitter (Saper, Chou et al. 2001), but it is 
less clear if this results in changes in the sleep EEG. 
 
CRH is released during the second half of the night and is thought to impair NREMS 
and impacts on the release of cortisol (Steiger 2007).  Cortisol also released from the 
HPA system affects sleep and mood (Gibson, Checkley et al. 1999).  Cortisol shows a 
circadian rhythm with a peak during the early morning hours (0400 - 0800) (Knutsson, 
Dahlgren et al. 1997) corresponding to periods of REMS, but can be significantly 
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altered by meal composition (Gibson, Checkley et al. 1999) and changes in meal timing 
(Bogdan, Bouchareb et al. 2001).  Levels of cortisol contribute to the maintenance of 
rapid eye movement sleep (REMS) through the feedback inhibition of CRH and certain 
neurotransmitters (Steiger 2007).  A study involving patients with insomnia indicates 
nocturnal cortisol secretion is not impaired compared to healthy individuals, however, 
nocturnal melatonin section was significantly diminished (Riemann, Klein et al. 2002).   
 
Melatonin, a neuropeptide, located in the pineal gland, is secreted at the onset of 
darkness, but suppressed by light.  Levels of melatonin peak between midnight and 
0200 h with the lowest levels in the afternoon (Kennaway and Voultsios 1998).  
Melatonin is considered a biological marker for the endogenous 24 h circadian rhythm 
(Ohashi, Okamoto et al. 1999).  Melatonin increases sleep propensity and promotes 
sleep consolidation (Bermudez 1983).  Periods of insomnia are associated with low 
nocturnal levels of melatonin, which results in elevated core body temperature 
(Dawson and Encel 1993). Indeed, exogenous administration of melatonin facilitates 
sleep onset (Brzezinski, Vangel et al. 2005) and even improves sleep in the blind who 
lack the environmental cue for its release (Jan, Espezel et al. 1994).  It is suggested that 
in humans melatonin produces a hypnotic effect indirectly through thermoregulatory 
mechanisms since exogenous melatonin induces a lowering of the core body 
temperature (Dijk and Cajochen 1997).  The core body temperature also acts as a 
marker for the endogenous circadian rhythm where periods of increasing temperature 
correlate with periods of alertness during the late afternoon, but temperature dips and 
nadir that occur around 0400 - 0600 h are associated with periods of sleepiness (Monk 
2005).   
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Neurotransmitters and sleep 
Figure 2.2 depicts the progression of synaptic activity and pre-empts the following 
description of the neurotransmitters activity involved in the regulation of sleep-wake 
states.  
 
Figure 2.2.  Synaptic relationships underlying the control of sleep and muscle tone; Adapted 
from Steigel 2004.  This illustration represents a sagittal section of a cat’s brain and illustrates 
the complexity of synaptic relationships involved in loss of consciousness and correlated loss 
of muscle tone that characterises normal sleep.  Lines ending in solid dots indicate inhibitory 
output.  Lines ending in arrows indicate excitatory output.  Abbreviations:  GABA, γ-
aminobutyric acid; GC = nucleus gigantocellularis; IO, inferior olive; LC = locus coeruleus; 
MC = nucleus magnocellularis; PIA = pontine inhibitory area; MP, nucleus paramedianus; 
PPN, pedunculopontine nucleus. 
 
  
Activity from neurons containing the neurotransmitters such as serotonin (5HT) and γ-
aminobutyric acid (GABA) are especially important, however other neurotransmitters 
such as dopamine, norepinepherine, and acetylcholine specifically influence various 
stages of sleep (Siegel 2004).   
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Neurons that discharge with sleep are located primarily along the anterior 
hypothalamus and basal forebrain, which represents a prominent region involved in 
sleep (Siegel 2004).  The neurons in the locus coeruleus of the pons contain 
norepinephrine, and the release of 5HT from the raphe nuclei, are similarly linked to 
sleep via mediation of muscle tone, resulting in a relaxed state.  The release of 5HT 
triggers subsequent sleep promoting mechanisms by triggering activity in the 
neighbouring SNC, where melatonin is released (Dawson and Encel 1993).  In fact, 
5HT is the intermediary product in the production of melatonin and therefore its 
production may also promote sleep (Blum, Vered et al. 1992).  Moreover, brain 5HT 
content is tightly controlled by the presence of the amino acid precursor, tryptophan, 
which is found in the normal dietary intake (Wurtman, Hefti et al. 1981).  Evidence in 
the animal model suggests brain 5HT activity is linked to REMS by the regulation of 
muscle tone, especially the phasic activity during REMS (Wu and Boehmer 2004).  
Remarkably, insomnia follows after lesions are made in either the raphe system or the 
pre-optic area where 5HT is a major neurotransmitter (McGinty and Sternman 1968). 
Furthermore, pharmaceuticals like selective serotonin reuptake inhibitors (SSRIs) 
promote 5HT levels in the brain and are highly efficacious in the management of sleep 
difficulties such as those presented with insomnia (Perlis, Giles et al. 1997). 
 
The activity of the serotonin system is widely mediated via projections from certain 
groups of neurons located in the basal forebrain and the anterior hypothalamus that 
contain the inhibitory neurotransmitter GABA (Siegel 2004).  GABA is the most 
common inhibitory neurotransmitter in the brain and its release induces sleep by 
inhibiting the cortical activation involved in arousal (Saper, Chou et al. 2001).  In fact, 
GABA also mediates the effects of various neuropeptides (e.g., galanin, somatostatin) 
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on the changes to sleep presented earlier.  The discharge rate of GABA neurons in the 
basal forebrain and anterior hypothalamus increases at sleep onset and continues its 
activity while sleep progresses (Steiger 2007).  In addition, about 25% of the neurons in 
the basal forebrain that project to the cortex to regulate sleep-wake states release the 
amino acid glutamate (Henny and Jones 2008).   
 
The hypocretin/orexin (orexins) system represents another more recently discovered 
group of specialised neurons whose role may be to prevent unwanted transitions 
between sleep-wake states (Saper, Cano et al. 2005).  Located anatomically between the 
prominent sleep (anterior hypothalamus and basal forebrain) and wake regions 
(posterior hypothalamus) in the lateral hypothalamus are neurons containing the 
neuropeptide orexins that can release both GABA and glutamate (Steiger 2007).  These 
neurons have been linked to cataplexy, a symptom of narcolepsy in which unwanted 
sleep episodes are experienced with a complete disinhibition of muscle activity 
(Sakurai 2005).  However, the mechanisms by which these neurons affect sleep-wake 
states are still controversial.  Remarkable is the ability of orexins to be both inhibited, 
thereby promoting sleepiness, or disinhibited, thereby promoting wakefulness, 
locomotor activity and foraging (Burdakov, Luckman et al. 2005).  
 
In contrast, those neurons located in the posterior hypothalamus represent a prominent 
region for the wake state (Siegel 2004).  These neurons have ascending projections 
toward the cortex and descending projections toward the brainstem which are active 
during waking (Jones 2003).  Other major connections involved in the control of 
wakefulness are located in the posterior hypothalamus, where neurons releasing 
histamine are abundant.  Lesions to this region have been shown to produce a coma-
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like state (Saper, Chou et al. 2001) and classic antihistamine medications are known to 
produce side-effects such as drowsiness (Meltzer 1990).  Finally, the neurotransmitters 
acetylcholine in the basal forebrain also plays a major role in the maintenance of 
wakefulness in the brain.  Cholinergic neurons stimulate muscle atonia during REMS 
(Jones 2003).   
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Circadian timing of meals 
It is known that sleep and metabolism are tightly regulated by the circadian clock that is 
located in the SCN of the hypothalamus (Kovac, Husse et al. 2009).  The body clock 
keeps time of all biological rhythms. Circadian rhythms are those with an oscillation of 
approximately 24 h.  These rhythms not only display peaks and troughs of activity at 
different times of the day, but show phase relationships.  For an example, the peak core 
temperature that occurs at around 1600-1800 h is linked to alertness, whereas the 
temperature nadir occurring at around 0400-0600 h is linked to sleepiness (Monk 
2005).  Not surprisingly, the time of day that meals are eaten exerts an influence on 
postprandial sleepiness.  A biphasic response was observed after a high-fat, low-
carbohydrate (HFLC) or a low-fat, high-carbohydrate meals (LFHC) meal provided at 
breakfast or lunch.  The response showed an increase in alertness that lasted for up to 
30 min followed by a shift towards sleepiness that was greatest between 1100 and 1400 
h independent of the meal type (Wells, Read et al. 1998).  The initial increase in 
alertness may be explained by the thermogenic effect of the meal, while the 
postprandial sleepiness coincides with the post-lunch dip, a circadian phenomenon 
(Monk 1987).  This phenomenon has been examined in a study where a 3 h sleep 
opportunity was allowed after either a CHO liquid lunch meal or a no food condition.  
Sleep occurred in both conditions suggestive of a strong post-lunch circadian dip 
(Zammit, Kolevzon et al. 1995). Importantly, sleep duration was markedly increased 
following food intake, suggesting that in addition to the circadian effect, the meal itself 
impacted sleep.  
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Harnish and colleagues queried if postprandial sleepiness was due to the ingestion 
process related to gustatory, olfactory and/or visual cues associated with a meal 
(Harnish, Greenleaf et al. 1998).  They explored this question using the Multiple Sleep 
Latency Test (MSLT) with four nap opportunities tested at 1700 h and terminating at 
2100 h.  They offered participants a mixed macronutrient meal (energy from fat 46% 
and from carbohydrates 42%) or a sham meal (chewed and expectorated) in a crossover 
study where the meal allocation was randomised and counter-balanced.  There was only 
a small difference in the sleep period between the feeding and sham feeding conditions 
at 2 h postprandially.  However, sleepiness was delayed with progression of the 
remaining nap studies, which likely reflects an increased state of alertness linked to the 
circadian temperature peak as well as the thermic effects of the meal.  
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Macronutrients and sleep 
Meals high in CHO and fats are more effective in promoting sleep compared to protein 
meals.  An increase in sleepiness has been reported at breakfast after high CHO meals 
compared to high protein meals (Leathwood and Pollet 1982/83).  Postprandial 
sleepiness after HFLC and HCLF meals may be present for up to 4 h depending on the 
measurement tool used.  Sleepiness measured by subjective scales was present at 60 
min after meal consumption (Leathwood and Pollet 1982/83; Spring, Maller et al. 
1982/83; Lloyd, Green et al. 1994; Lloyd, Rogers et al. 1996; Wells, Read et al. 1997; 
Wells, Read et al. 1998), whereas sleepiness measured by objective measures occurred 
between 1.5 to 4 h (Wells, Read et al. 1998).  Increased sleepiness measured by the 
MSLT was present at 1.5 h after meal ingestion, whereas that measured by the 
Akerstedt EEG sleepiness test (spectral analysis of EEG) was present at 3 h 20 min. 
 
Early evidence showed that SWS is immediately increased after intravenous 
administration at bedtime of either pure glucose or of an amino acid mixture, whereas 
increases in REMS occurred after glucose administration only (Lacey, Stanley et al. 
1978). Dietary intake of CHO showed appropriate trends in REMS.  A dose-response 
effect for increased REMS was present after isocaloric diets with low (100 g), medium 
(300 g), and high (600 g) CHO content (Phillips, Chen et al. 1975).  Further, an 
increase in REMS was evident after a low calorie CHO snack given 45 min before the 
usual bedtime (Porter and Horne 1981).  In accordance with these results, a reduction in 
CHO intake such as either 50g/day (Kwan, Thomas et al. 1986) or complete absence. 
(Afaghi, O'Connor et al. 2008) resulted in a reduction in REMS, total sleep time, and 
increased SWS.  Recently, a link between the type of carbohydrate intake and sleep 
initiation has been presented.  Afaghi et al. 2007 tested the efficacy of a high versus a 
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low GI CHO meal and the timing of the high GI meal (4 h versus 1 h before the usual 
bedtime) on the sleep patterns of healthy adults.  The subjects took significantly less 
time to fall asleep after the high GI compared to the low GI isocaloric meal eaten 4 h 
before their usual bedtime.  They also took less time to fall asleep after the high-GI 
meal ingested 4 h before bedtime than after that ingested 1 h before bedtime.  
Moreover, there were no differences to other stages of sleep (Afaghi, O'Connor et al. 
2007).  In a separate study, when a cereal-type bedtime snack was given just prior to 
bedtime there was a reduction in sleep latency and a more restful sleep reported in 
healthy subjects (Brezinova and Oswald 1972).  Thus, it is apparent daily food choices, 
and especially CHO intake, may positively influence sleep quality by promoting sleep 
onset, REMS, and total sleep duration.   
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Macronutrients and neurochemicals 
The link between CHO intake and increased sleepiness is dependent on the GI of a 
meal.  The GI has been shown to dictate the availability of tryptophan (TRP) to the 
brain.  Dietary TRP is a crucial amino acid that links diet and sleep, given it is the 
biological precursor to 5HT, an intermediary to the synthesis and release of melatonin.  
The availability of TRP to the brain depends on its concentration in relation to the other 
large neutral amino acids (LNAA), since each competes for a single transport protein 
across the blood brain barrier (Wurtman 1988).  Postprandial sleepiness may, therefore, 
be linked to the post-absorptive mechanisms leading to changes to plasma TRP/LNAA 
concentration.   
 
Figure 2.3 illustrates the postprandial change in TRP/LNAA levels after two CHO-
based meals (sucrose, high GI; raw starch, medium GI) and one fat plus protein meal.  
There is a clear GI dose-dependent increase in TRP/LNAA levels after CHO-based 
meals, and a decline after a protein plus fat meal (Lyons and Truswell 1988).  This 
response has been replicated elsewhere (Ashley, Liardon et al. 1985; Caballero, Finer et 
al. 1988; Wurtman, Wurtman et al. 2003).  The time required for digestion and 
absorption of nutrients relates to the plasma appearance of TRP, since TRP/LNAA 
levels peaks between 2-4 h after ingestion.  This peak rise in plasma TRP/LNAA 
concentration has been replicated for meals provided in the evening (Lyons and 
Truswell 1988) providing supportive mechanistic evidence for sleep improvement after 
high GI CHO ingestion.   
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Figure 2.3.  Postprandial change in TRP/LNAA levels after two carbohydrates and a fat plus 
protein meal.  The mean change in plasma TRP/LNAA concentration in 13 subjects after 
sucrose (high GI), raw starch (medium GI), or fat+protein evening meals is shown. Vertical 
bars represent SEM. Values after sucrose were significantly different from corresponding raw-
starch (p < 0.05, Neuman-Keul’s test).  Values after fat+protein were significantly different 
from both corresponding carbohydrate meals (p <0.001).  TRP: tryptophan. LNAA: large 
neutral amino acids. GI: glycemic index.  Data are from Lyons and Truswell (1988), with 
permission from the Publishers. 
 
High GI meals, through hastened entry of glucose into the blood, facilitate a greater 
insulin response that mediates the selective uptake of LNAA into skeletal muscle, 
leaving TRP that is largely bound to plasma albumin free to cross into the brain for 
conversion into 5HT (Fernstron and Wurtman 1972).  Indeed, this cascade of events 
has been shown to lead to an increase in 5HT production.  Figure 2.4 shows the 
postprandial levels of platelet-poor plasma (PPP)-5HT after a CHO, fat, or protein rich 
meal (Blum, Vered et al. 1992).  As can be seen the level of PPP-5HT was significantly 
increased from baseline after the CHO-rich meal (4.47 fold) compared to after the fat-
rich meal (1.66 fold), reflecting a reduction in the glycemic response when fat is added 
to a meal.  Increased PPP-5HT is likely responsible for the increase in REMS after 
CHO intake, since increased levels of plasma tryptophan correlate positively with 
REMS in normal individuals (Chen, Kalucy et al. 1974).  
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Figure 2.4.  Effects of meal composition on platelet poor plasma serotonin (5HT) in healthy 
individuals.  Percent change observed in platelet poor plasma 5HT levels after the 
administration of test meals: meal 1, carbohydrate; meal 2, protein-rich; meal 3, fat-rich. 5HT: 
5-hydroxytryptamine or serotonin. Data are from Blum et al. (1992). 
 
The increase in postprandial sleepiness after fat-based meals may be explained by the 
release of the neuropeptide cholecystokinin (CCK) in response to the delivery of fatty 
acids and protein rich chyme to the duodenum.  Increased CCK levels are present at 
approximately 3 h after digestion of HFLC meals or after intraduodenal infusion of 
lipids (Wells and Read 1995).  In this study, increased sleepiness was present after both 
conditions compared to saline infusion.  It is likely that postprandial sleepiness after 
ingestion of fat is mediated by vagal afferent signals to the brain (Schwartz, McHugh et 
al. 1993).  Evidence in the animal model corroborates these findings (Murray, Clarke et 
al. 1993).  Despite the soporific effects of high fat meals, increased fat intake may lead 
to positive energy balance and may contribute to weight gain, and thus should be 
avoided.  
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Habitual feeding behaviours, gender, and sleep  
It is apparent that habitual food choices and gender both greatly influence subjective 
sleepiness.  Meals that deviate from habitual intake with respect to the time of day, 
volume, or macronutrient content may cause a decline in subjective mood state and 
increased sleepiness (Lloyd, Green et al. 1994; Wells and Read 1994; Lloyd, Rogers et 
al. 1996).  It is unclear if the carbohydrate feeding behaviour and choice of foods at 
breakfast have a physiological basis.  However, it is possible that this behaviour is 
signalled by a low blood glucose level following an overnight fast (Robertson, 
Henderson et al. 2002) and may be synchronised with the sleep-wake cycle (Krauchi, 
Cajochen et al. 2002).  After a LFHC breakfast meal, mood improves and fatigue 
decreases compared to a HFLC meal, a mixed macronutrient meal, and when no 
breakfast meal was provided (Lloyd, Rogers et al. 1996).  In addition, subjective 
alertness declined after big lunches compared to small lunches irrespective of habitual 
lunch size (Craig and Richardson 1989).  Further, solid meals, but not liquid meals 
increase sleepiness compared to an equal volume of water (Orr, Shadid et al. 1997).   
 
Gender may also modify the dietary effects on sleepiness.  In women, a decline in 
alertness is more prominent for those eating larger sized-meals compared with their 
usual sized lunch-time meals (Smith, Ralph et al. 1991).  In another study, women 
tended to report greater postprandial sleepiness than males throughout the day (Wells 
and Read 1996).  Other subjective mood states such as feelings of lethargy, boredom, 
and mental slowness have been reported across genders independent of meal type 
(Smith, Leekam et al. 1988).  Thus, it appears that women may be more susceptible to 
postprandial sleepiness. 
 
 - 25 - 
Application to health and disease 
In summary, macronutrients may be suitable and used to an advantage in the 
management of sleep difficulties in shift workers and persons with insomnia.  Sleep 
initiation and duration may improve by using moderately high GI foods when sleep is 
planned (i.e., after a night shift).  Given that the efficacy of high GI foods on sleep is 
founded on the availability of tryptophan, natural foods rich in tryptophan (milk, 
yoghurt, spinach) are particularly suitable in combination with a CHO-based meal.  
Choosing a light meal low in GI with a portion of protein when alertness is desired 
(i.e., during a night shift) may circumvent postprandial sleepiness and lethargy as sleep 
propensity increases.  Since high fat meals and the size of the meal promote sleepiness, 
avoiding such foods may reduce postprandial sleepiness.   
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CHAPTER 3: Study protocols and related concepts 
 
The protocols for the dietary and sleep interventions and related concepts are described 
in this section.  Detailed methodologies are described within the relevant study 
chapters. 
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Glycemic Index (GI) and glycemic load (GL) 
The GI refers to a number scale from 0-100 which is used to express the extent of the 
postprandial rise in blood glucose in response to the ingestion of CHO from a meal 
(Thorburn, Brand et al. 1986).   The relative CHO content of a meal contributes to the 
major rise in blood glucose.  The addition of protein and fat to a meal reduces the peak 
rise and overall glycemic effect by increasing the time required for digestion and gastric 
emptying (Cooke 1975; Ercan, Gannon et al. 1994).  High GI foods are rapidly digested 
and absorbed into the body resulting in a marked increase in blood glucose levels, 
whereas low GI foods produce only gradual increases in blood glucose levels (Brand-
Miller 2009).  Low GI foods improve overall metabolic control of diabetes through 
control of blood glucose, insulin, and lipid levels (Opperman, Venter et al. 2004).  
These foods have the potential to control weight gain by their ability to delay hunger 
(Radulian, Rusu et al. 2009).  Because the GI is a relative ranking of foods containing 
the same amount of CHO it will always remain the same despite larger quantities being 
consumed (Brand-Miller 2009).   
 
The glycemic load (GL) was introduced to describe the overall glycemic effect of a 
portion of food (Salmeron, Ascherio et al. 1997).  This value takes into account the 
specific serving size and the GI of a food.  Therefore, the GL can be used to describe 
the metabolic effect of different amount and types of CHO (Brand-Miller 2009).  At 
least in healthy, young men, it appears the GL, and not the GI, is a more reliable 
measure of the overall glycemic response and insulin demand (Brand-Miller, Thomas et 
al. 2003).  Thus, the higher the GL, the greater the expected glycemic and insulin 
response of the food (Foster-Powell, Holt et al. 2002).   
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The GI of a food can be determined after a series of test in which finger-prick blood 
samples are obtained from at least 10 healthy participants to measure levels of blood 
glucose for at least 2 h to construct blood glucose curves (Brouns, Bjorck et al. 2005).  
Participants are given a reference food and then a series of test foods in random order, 
each at least 48 h apart.  The GI is calculated by comparing the incremental area under 
the curve (AUC) of the test food to the AUC of the reference food and multiplying by 
100 (Figure 3.1 and Equation 1).  The reference food, typically of 50 g pure glucose, 
must be equivalent to the available CHO (g) from the test food in order for accurate GI 
measurement.  In the presented thesis, a 75 g glucose load was necessary because the 
mixed macronutrient meals each contained 75 g available CHO.  These meals were 
designed to provide sufficient energy for adults when provided as a dinner meal.  
 
Equation 1 
GI = 120 min AUC of test food 
Mean AUC from reference food 
 
GL = (GI/100) x available g CHO  
 
 
 
Figure 3.1.  Determination of GI using the area under the curve method.  This figure 
illustrates a typical 2 h blood glucose curve.  The AUC of a meal represents the total area 
above baseline (shaded areas) only.  Diagram adapted from Brouns et al. 2005.  
 
 
Foods designated as high GI will have an index of at least 70, medium at least 56, and 
anything below is considered low GI (Foster-Powell, Holt et al. 2002).  The cut-off for 
high GL is a value ≥ 20 and for low GL ≤ 10; medium GL is 0-19 (Brand-Miller, Holt 
et al. 2003).  A high GL over an entire day is a value ≥ 120 (Brand-Miller 2009). 
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Research Diagnostic Criteria (RDC) for Insomnia 
Standardised sleep questionnaires were used to establish research diagnostic criteria 
(RDC) for insomnia in accordance with published guidelines (Edinger, Bonnet et al. 
2004).  The Pittsburgh Sleep Quality Index (PSQI) and the Insomnia Severity Index 
(ISI) were administered to document the presence of insomnia as defined by the 
following research criteria: (1) a disturbed quality of sleep (PSQI ≥10); (2) sleep 
initiation of equal to or greater than 30 min, at least three times per week (PSQI, ISI); 
and an (3) ISI index of at least 11.  The PSQI also established problems with sleep 
quality, duration, and efficiency, but were not required to meet the RDC for insomnia.   
 
The PSQI (Buysse, Reynolds et al. 1989) contains 19 self-administered questions and 
five additional questions for the bed partner; the former only included in the overall 
score to assess sleep quality and disturbances over the last month (Appendix A).  The 
PSQI score is grouped into seven subjective sleep components: sleep quality, sleep 
latency, sleep duration, sleep efficiency, sleep disturbances, the use of sleeping 
medications, and daytime dysfunction.  The total score for the PSQI is from 0-21, “0” 
indicating no difficulty and “21” indicating severe difficulties in all areas.  The PSQI is 
a validated instrument used to discriminate poor (PSQI ≥ 6) from good sleepers, but 
was not specifically designed to reflect the clinical assessment of insomnia (Bastien, 
Vallieres et al. 2001). 
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The ISI (Bastien, Vallieres et al. 2001) is a brief self-administered and validated 
questionnaire designed specifically to assess the perception of subjective symptoms of 
insomnia as well as the level of distress caused by these symptoms.  The ISI contains 7 
questions (Appendix A) to assess sleep onset and sleep maintenance difficulties, 
satisfaction of current sleep pattern, interference with daily functioning, noticeability of 
those problems by others, and the degree of distress or concern caused by these 
symptoms over the last two-week period.  Each question is rated on a 0-4 scale with a 
total score of 28.  Higher scores (above 22) suggest severe insomnia, scores between 15 
and 21 suggest moderate insomnia, between 8 and 14 suggest sub-threshold insomnia, 
and between 0-7 are considered as no significant insomnia.  Whilst a structured 
diagnostic interview remains the “gold-standard” for the evaluation and diagnosis of 
insomnia, the ISI is considered a reliable tool for screening and evaluation of insomnia 
in research and clinical settings (Morin and Espie 2003).  A recent study has 
highlighted that the incidence and temporal pattern of insomnia is such that untreated 
patients experience a ‘good sleep’ as much as 50% of the time over a two-week period.  
Thus, a cut-off score of 11 was arbitrarily reflecting a value in the middle of the sub-
threshold insomnia range.   
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Polysomnography (PSG) 
PSG is considered the “gold-standard” procedure used to diagnose and evaluate 
treatment of various sleep disorders such as the forms of sleep disordered breathing 
(i.e., obstructive sleep apnoea) and periodic limb movements (Kushida, Littner et al. 
2005).  PSG is also indicated to support the clinical diagnosis of insomnia when there 
is a need to rule out other sleep disorders.  During PSG, differential electrical potentials 
collected through scalp and skin surface electrodes are recorded.  Comprehensive PSG 
can record up to 64 channels using sophisticated digital polygraph equipment and 
include measures such asl; brain wave activity, eye movement activity, skeletal muscle 
activity – typically of the masseter and anterior tibialis, respirations and respiratory 
effort, snoring sounds, plethysomnography (oxygen saturation) and others as indicated.   
 
Objectively measured brain wave activity, electroencephalography (EEG), offers a 
dimension of sleep not attainable by subjective sleep measures.  EEG measures reveal 
sleep is usually entered through Stage 1 drowsy sleep, followed by “true” sleep (Stage 
2) characterised by the sleep EEG spindle structure, and followed by Stage 3 or slow 
wave sleep (SWS) and rapid eye movement sleep (REMS).  Stages 1-3 do not exhibit 
rapid eye movements and are collectively known as non-rapid eye movement (NREM) 
sleep.  In a normal adult sleep pattern, there are approximately 4-6 cycles of NREM and 
REM sleep; each cycle is between 90 to 120 minutes in duration (Roth 2004).  During 
NREM sleep, cognitive activity is often reduced or fragmented and major body 
movements occur, however, skeletal muscle tone progressively decreases as this sleep 
state moves from light sleep of stages 1 and 2 to deep sleep of stage 3 or SWS.  In 
contrast, during REMS, cognitive activity increases yet the body becomes nearly 
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paralysed with muscle atonia, and punctuated by phasic muscle twitches.  Figure 3.2 is 
a hypnogram depicting the sleep pattern of an adult regular sleeper. 
 
Both the SWS and REMS exhibit polarity during nocturnal sleep. SWS occurs in 
abundance during the first sleep cycle, whereas REMS predominates in the latter half as 
individual periods become longer, especially prior to waking.  The distribution of the 
total sleep time for normal adult sleep stages is approximately 5% for NREM 1, 50% 
for NREM2, 20% for NREM 3, and 25% for REMS (Iber, Ancoli-Israel et al. 2007).   
 
 
Figure 3.2.  Hypnogram depicting the normal sleep pattern in adults.  This figure illustrates 
the progression from awake through the various forms of sleep stages.  The normal sleep 
pattern consists of 4-6 cycles of NREM and REM sleep.  Note, stage 3 and stage 4 are now 
referred to as SWS collectively according the most recent guidelines set by the AASM (2007). 
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PSG Protocols 
Recordings to collect EEG sleep data were conducted using the Compumedics S- and 
W-Series sleep system (Compumedics Pty Ltd, Australia) connected to a personal 
computer.  A standardised procedure for the location and application of scalp and skin 
surface electrodes was completed according the American Academy of Sleep Medicine 
(Iber, Ancoli-Israel et al. 2007) and described in the subsequent section (Electrode 
Placement).  Table 3.1 describes the PSG signal types, physiological responses 
monitored during all recordings and the type of electrode used.   
 
Table 3.1.  PSG signal types 
 
Signal type Physiological responses Electrode Type 
   
ECG Heart rate Adhesive, snap 
EEG Brain wave activity Various scalp sites 
EOG Eye movement activity Adhesive, snap 
EMG Skeletal muscle activity Adhesive, snap 
Snore Audible snoring Microphone 
Airflow Respirations Thermocouple 
Effort Abdominal  and thoracic  
respiratory Effort 
Inductive-band 
plethysomnography 
Sa02 Peripheral oxygen concentration Finger monitor 
Position Body positions Compumedics 
Abbreviations:  ECG, electrocardiogram; LOC, left oculargram; ROC, right oculargram; 
EMG, electromyogram; LLEG, left leg; RLEG, right leg; Airflow, airflow thermistor; Sa02, 
peripheral oxygen saturation. 
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Electrode Placement 
The EEG scalp electrode placement was completed in all recordings in accordance with 
the guidelines of The International 10-20 System (Jasper 1958).  This system 
documents the standard technique used worldwide to ensure the appropriate location, 
application, and terminology of EEG scalp electrodes to allow for accuracy of 
interpretation of EEG signals.  Figure 3.3 illustrates the appropriate electrode sites and 
shows the appropriate final setup.  The electrooculargram (EOG) channels designated 
LOC (left eye) and ROC (right eye) is not shown.  These were placed 1cm laterally 
from the outer canthus of each eye and 1cm below and above, respectively.  
Modifications were made using Fz as a reference electrode (REF) and a grounding 
electrode (GND) in the middle forehead; the chin EMG electrodes were placed on the 
left (EMG1) and right (EMG2) side of the cheek to monitor muscle activity of the 
masseter.  The electrocardiogram (ECG) was obtained using 2 adhesive type electrodes 
placed 1cm above the collar bone on the left (ECG1) and right (ECG2) side of the 
body.  The detailed procedure is described as follows: 
 
Figure 3.3.  Appropriate electrode sites during PSG.  This figure illustrates the nomenclature 
and site for standard PSG electrodes according to the International 10-20 System. 
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First, locate electrode sites by measuring the distance between the nasion and inion, and 
between the left and right preauricular points.  Mark the appropriate electrode sites (C4, 
01, REF, GND, A1, A2, Chin EMG 1 and 2) and prepare each by using abrasive gel 
(Nuprep, DO Weaver, USA) and cotton-tip applicator.  Remove excess and clean skin 
of oils using alcohol wipe (Medi-Swab 70% Isopropyl alcohol).  Collect EC2 electrode 
cream (Grass Technologies, Rhode Island, USA) neatly inside Ag/Cl cup electrode 
(Grass Technologies).  Collect 2cm x 2cm gauze pad and cover with electrode cream, 
EC2, (Grass Technologies).  Place electrode onto appropriate scalp site (C4, O1, and 
REF) securing with a 2cm x 2cm gauze pad.  Collect adhesive electrode (Meditrace 
100, Tyco Healthcare, USA), attach to snap wires (Grass Technologies), and place on 
appropriate head location (A1, A2, LOC, ROC, GND and Chin EMG).  Collect all 
electrode wires and insert into appropriate signal location on the PSG system head box 
and connect to amplifier.  Manoeuvre wires behind the closest side of the head securing 
behind the ear.  Take wires at front of the head, underneath the chin and wrap 3 times 
with gauze strips at intervals of approximately 20 cm.   
 
Tables 3.2 and 3.3 describe the recording montages used for the familiarisation (night 
1) and test recording nights (nights 2-5), respectively.  During the familiarisation night 
additional signals were placed according to published guidelines to screen for comorbid 
sleep disorders (i.e., obstructive sleep apnoea, PLMD).   
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Table 3.2.  PSG recording montage for the familiarisation night 
 
Channel Polarity Sensitivity 
(Zoom) 
High 
Pass 
Filter 
(Hz) 
Low 
Pass 
Filter 
(Hz) 
Notch Filter 
(Hz) 
      
ECG1-ECG2 Positive 4.0 0.3 30 50 
C4 – A1 Negative 8.0 0.3 35 50 
01 – A2 Negative 8.0 0.3 35 50 
LOC – A2 Negative 8.0 0.3 35 50 
ROC – A1 Negative 8.0 0.3 35 50 
EMG1-EMG2 Positive 4.0 10 100 50 
Snore microphone Positive 4.0 10 100 50 
LLEG1-LLEG2 Positive 10 10 100 50 
RLEG1-RLEG2 Positive 10 10 100 50 
Airflow  Positive 10-100 0.1 15 Off 
Thoracic Effort Positive  10-100 0.1 15 Off 
Abdominal Effort Positive 10-100 0.1 15 Off 
Sa02 Positive None None None Off 
Body Position None None None None Off 
Abbreviations:  ECG, electrocardiogram; LOC, left oculargram; ROC, right oculargram; 
EMG, electromyogram; LLEG, left leg; RLEG, right leg; Airflow, airflow thermistor; Sa02, 
peripheral oxygen saturation.  The ECG, Snore microphone, LLEG, RLEG, thoracic and 
abdominal effort, Sa02, and body position sensors were used to identify activity consistent 
with medical comorbity (i.e., sleep apnoea, PLMD). 
 
Table 3.3.  PSG recording montage for testing nights 
 
Channel Polarity Sensivity/ 
Zoom 
High Pass 
Filter 
(Hz) 
Low Pass 
Filter 
(Hz) 
Notch Filter 
(Hz) 
C4 – A1 Negative 8.0 0.3 35 50 
01 – A2 Negative 8.0 0.3 35 50 
LOC – A2 Negative 8.0 0.3 35 50 
ROC – A1 Negative 8.0 0.3 35 50 
EMG1-EMG2 Positive 4.0 10 100 50 
Abbreviations:  ECG, electrocardiogram; LOC, left oculargram; ROC, right oculargram; 
EMG, electromyogram. 
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Physiological Calibrations 
After completion of the electrode placement each subject was asked to lie on their back 
and instructed to perform various manoeuvres that are designed to simulate sleep-
related behaviours. The resulting tracings were annotated on the personal computer and 
carefully examined to verify correct signal derivations and signal quality (i.e., electrical 
impedance ≤ 10 kOhm).  Any indication of poor signal transmission, instrument 
failure, or the presence of interfering signals were addressed at this time. The 
physiological calibrations performed during PSG recordings are as follows: eyes closed 
for 30 s, eyes open for 30 s, look left and right for 5 s, look up and down for 5 s, blink 
eyes five times slowly, clinch jaw or grind teeth.  In addition, on the first night 
(familiarisation), the following responses were measured; make a snoring sound three 
times slowly, flex left foot only, flex right foot only, hold breath for 10 s, breath 
through your nose only for 30 s, breath through your mouth only for 30 s. 
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Sleep and EEG arousal scoring 
Standardised guidelines for the appropriate recognition and notation of sleep stages 
were followed according to the American Academy of Sleep Medicine (Iber, Ancoli-
Israel et al. 2007) using standard 30 s epochs.  An epoch is the term used to describe 
the digital polygraph on the personal computer and is comparable to what would be 
seen on paper using an analogue system.  Table 3.4 describes the appropriate EEG, 
EOG, and EMG activity used to identify the individual sleep stages of NREMS (1-3) 
and REMS.  Sleep scoring was completed by a researcher blinded to the experimental 
conditions (CMC). 
 
Table 3.4.  Sleep stage scoring criteria 
 
Sleep Stage EEG EOG EMG 
Wakefulness, 
alert 
Low voltage, mixed-
frequency (beta rhythm) 
Voluntary eye 
movements 
Increased tonic 
activity 
Wakefulness, 
drowsy 
Low voltage, mixed 
frequency (alpha rhythm) 
Voluntary eye 
movements 
Increased tonic 
activity 
NREM Stage 1 Theta waves / vertex 
waves, low voltage mixed 
frequency 
Slow rolling eye-
movements 
Decreased tonic 
activity from 
wakefulness 
NREM Stage 2 Sleep spindles, k-
complexes, mixed 
frequency waves 
Occasional slow 
rolling eye-
movements then 
similar to EEG 
Tonic activity, low 
threshold 
NREM Stage 3 
or SWS 
Delta waves 
predominates, moderate 
voltage activity 
No eye 
movements, 
follows EEG 
Tonic activity, low 
threshold 
REM  Low voltage, mixed 
frequency; saw tooth 
waves, theta bursts 
Phasic rapid eye-
movements; or 
periods of tonic 
activity 
None; muscle 
atonia, phasic 
twitches 
EEG rhythm frequency: beta > 14 Hz, alpha 8-13 Hz, theta 4-7 Hz, delta < 0.5-2Hz; sleep 
spindle, train of distinct waves of 11-16Hz with a duration of ≥ 0.5 s;  
K-complex, distinctly sharp negative wave followed by a positive component with total 
duration ≥ 0.5 s 
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EEG arousals were scored using the criteria provided by the American Academy of 
Sleep Medicine (Iber, Ancoli-Israel et al. 2007).  The general definition used to 
describe an EEG arousal is as follows: 
 
“An arousal is defined as an abrupt shift in EEG frequency 
that occurs during sleep and lasts between 0.5 and a 
maximum of 14.9 s.” 
 
The rules described below were also applied to the primary (C4) and secondary (O1) 
EEG channels and the EMG channel as appropriate to confirm EEG arousals: 
• Subject must be asleep for at least 10 s and there must be at least 10 s of 
intervening sleep between arousals 
• Arousals in NREMS may occur without concurrent increases in EMG activity 
• Arousals in REMS must occur with an increase in EMG activity 
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PSG sleep variables 
PSG sleep variables studies were computed as per the digital polygraph specifications 
(Compumedics Pty Ltd, Australia). 
  
• Lights Out: start of recording (1 min after physiological calibrations) 
• Sleep Onset Latency (SOL):  time from lights out to the third consecutive 30 s 
epoch of NREM 1 or first epoch of any other stage.  “Start of sleep.” 
• Rapid Eye Movement Latency (REML):  time from SOL to the onset of the first 
REM sleep epoch 
• Sleep Period:  time from SOL to last 30 second epoch of sleep including 
intervening periods of wakefulness 
• Non-Rapid Eye Movement Sleep (NREM):  The sum of all NREM sleep stages 
(1, 2, and 3) 
• NREM Stage 1: the sum of all stage 1 sleep time within the sleep period 
• NREM Stage 2: the sum of all stage 2 sleep time within the sleep period 
• NREM Stage 3: the sum of all stage 3 sleep time within the sleep period 
• Rapid Eye Movement Sleep (REMS): the sum of all REM sleep time within the 
sleep period 
• Total Sleep Time (TST):  the sum of all sleep time including any sleep stage 
within the sleep period 
• Wake After Sleep Onset (WASO):  the sum of all time spent awake during the 
sleep period 
• Arousal Index:  the number of EEG arousals (see Arousal Scoring) per hour of 
sleep period 
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Respiratory events, limb movements, and snoring 
During the familiarisation night additional rules were applied to the PSG channels of 
respiratory related events, limb movements, and peripheral oxygen saturation to 
identify the presence of sleep disordered breathing or periodic limb movement disorder 
(PLMD).  Briefly, periods of reduced airflow and/or respiratory effort with a 3% drop 
in peripheral oxygen saturation (hypopnoea), periods without breathing (apnoea), 
snoring, and limb movements were noted and tabulated during the sleep period.  
Standardised guidelines were used to assess these data against the presence of 
obstructive sleep apnoea or PLMD as indicated by an appropriate index of 5 or 15 
events/hour of sleep, respectively (Redline, Budhiraja et al. 2007). 
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CHAPTER 4:  A meta-analysis of the first night effect (FNE) 
 
The enclosed study at the time of writing this thesis was in review as follows: 
 
C.P. Herrera & C.M. Chow (2010). A Meta-Analysis of the First Night Effect (FNE).  
In revision: Journal of Clinical Sleep Medicine. MS # JC-00030-09 
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ABSTRACT 
 
Introduction:  It is well established that sleep on the initial night during PSG is poor in 
relation to a subsequent night.  To account for this first night effect (FNE) it is common 
practice to provide a familiarisation period and to discard data before subsequent 
analysis.  To date, the characteristics and magnitude of the FNE have not been 
quantitatively reviewed.  
 
Methods:  A systematic literature search was performed to identify consecutively 
recorded data on PSG sleep variables.  Meta-analysis was completed using MIX (Meta-
analysis with Interactive eXplanations, Bax, Leon).  The study population, sleep 
setting, recording montage, sleep period, and age were used as moderating factors.   
 
Results:  Meta-analysis was completed in healthy sleepers (a total of 24 studies 
reporting on 421 subjects).  The FNE was characterised by a prolonged SOL (4.46 
min), delayed REML (20.55 min), increased WASO (3.88 %), and reductions in REMS 
(-2.17 %), TST (-18.81 min), and SE (-4.66%; all p < 0.01).  Studies conducted in the 
laboratory demonstrated a two-fold increase (Qb 6.83, p < 0.01) for the delayed REML 
compared to those in the home (22.73 vs. 11.36 min, respectively, both p<0.01).   
 
Conclusions:  This study provides the first quantitative analysis to confirm and 
describe the characteristics of the FNE in healthy sleepers.  These findings show a clear 
estimate of the magnitude of change in 9 PSG sleep variables across the first two 
consecutively recorded nights.  These data substantiate the common practice to treat the 
first recording night during PSG as a familiarisation period.  Further research is needed 
before a concise statement about the FNE can be made in clinical groups of insomnia 
and depression.   
 
 
 
 
 
Keywords:  FNE, First night effect, PSG, Healthy, Methodology 
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INTRODUCTION 
 
An early paper by Retschaffen and Kales (1964) reported an adaptation effect to the 
sleep laboratory.  This study investigating the influence of monetary incentives for 
controlling dreaming in healthy men (20-30 y), showed a lower REM sleep duration on 
the first of four consecutive nights (Rechtschaffen and Verdone 1964).  Agnew et al. 
(1966) described this phenomenon as the first night effect (FNE) reporting an increased 
wakefulness, less rapid eye movement (REM) sleep, and a delayed onset of slow wave 
and REM sleep (Agnew, Webb et al. 1966).  Other studies have reported a delayed 
sleep onset, lower sleep efficiency and decreased total sleep time (Toussaint, Luthringer 
et al. 1997; Lorenzo and Barbanoj 2002; Curcio, Ferrara et al. 2003).  Since these early 
reports it has become common practice to treat the first night of PSG as a 
familiarisation period and data is typically discarded before baseline measures are 
obtained and subsequent analysis is conducted.  However, over the last 4 decades many 
attempts have been made to evaluate the FNE with respect to common methodological 
factors.  
 
The sleep setting, type of participant, and age are among the most important factors 
influencing the FNE (Lorenzo and Barbanoj 2002).  Compared to the laboratory, an 
attenuated FNE is often reported when studies are conducted in the home (Coates, 
George et al. 1981; Zucconi, Ferini-Strambi et al. 1996).  Forms of sleep pathology 
such as insomnia and depression contribute to additional night-to-night variability in 
sleep quality (Edinger, Marsh et al. 1991) and sleep fragmentation (Mendels and 
Hawkins 1967), therefore it is as yet unclear if these clinical groups share the same 
FNE characteristics as healthy sleepers.  Further, treating the first night as a 
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familiarisation period gives the opportunity to screen for sleep disorders in otherwise 
healthy subjects.  However, the added respiratory effort bands, limb movement 
electrodes, and oximeter finger probe may impact negatively on sleep quality and 
contribute to a more pronounced FNE (Agnew, Webb et al. 1966; Johns and Dore 
1978).  Moreover, the removal of these electrodes on a subsequent night may 
differentially influence the sleep response.  Another methodological factor that may 
influence the FNE may be the sleep period.  During PSG studies the sleep period may 
be fixed or can be provided ad libitum.  When the sleep period is provided ad libitum it 
incorporates usual circadian timing of sleep and waking and offers optimal sleep 
opportunity.  On the other hand, a fixed sleep period in research studies may impose 
unfavorably on sleep onset latency or total sleep time, and may truncate REMS, 
potentiating a rebound on the subsequent night (Rotenberg, Kayumov et al. 1997).   
 
Importantly, exclusion of first night PSG data corresponds to a substantial loss and 
significant additional cost with respect to personnel, equipment, and consumables 
(Woodward, Bliwise et al. 1996).  To date, a quantitative review documenting the 
characteristics and magnitude of the observed FNE has not been conducted.  Thus, the 
common familiarisation period during PSG has not been empirically validated.  The 
present systematic review and meta-analysis examined the FNE observed during sleep 
investigations with consecutively recorded PSG data in healthy adults and patients with 
insomnia or depression.  In addition, exploring key methodological factors (study 
population, sleep setting, recording montage, sleep period, and age) provides 
meaningful interpretations to aid in PSG study designs. 
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METHODS 
 
Systematic Search 
A systematic review of the literature was undertaken on the 1st December 2009 using 
an online search of the MEDLINE (from 1950) and PsychINFO (from 1967) databases.  
Keywords used to identify English language sleep investigations reporting data on the 
FNE were (sleep, EEG, polysomnography, or PSG) and (first night effect or FNE).  
Additional references were collected from a previously unpublished search.  
  
Selection of published studies 
Included studies reported nocturnal sleep data on at least two consecutive nights in 
adults aged greater than 17 y to minimise variance from childhood and adolescent sleep 
patterns (Ohayon, Carsadon et al. 2004).  Sleep data were required on at least one of the 
following 9 sleep variables: sleep onset latency (SOL min), REM latency (REML min), 
total sleep time (TST min), wake after sleep onset (WASO, %TST), sleep efficiency 
(SE %), or the percentage of TST spent in the following stages: non-rapid eye 
movement stages 1 or 2 (NREM1, NREM2), slow wave sleep (SWS), and REM sleep 
(REMS).  These variables were chosen since they are among those commonly impacted 
by the FNE.  Also, these are among those recommended during PSG (Kushida, Littner 
et al. 2005).  Exclusion was made as follows: First, all abstract and conference 
proceedings were excluded.  Second, reports involving patients who had medical 
comorbidity (i.e., pain disorders, epilepsy, sleep disordered breathing, periodic limb 
movements) were excluded to minimise related effects on sleep.  Third, a series of 
other exclusions were met if the reported data were:  (1) after an initial adaptation 
period, (2) from non-consecutive recordings, (3) presented as an average of two nights, 
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(4) from experimental or comparative trials (e.g., placebo administration or comparing 
personality traits), or (5) involved participants with prior experience in sleep testing.  
Reports involving participants with prior experience of sleep testing were excluded as 
their familiarity with the environment or testing procedure may minimise the 
disruptions to their sleeping pattern (Clausen, Sersen et al. 1974).   
 
All retrieved studies were assessed for possible inclusion and relevance by inspection 
of full-text papers by one reviewer.  A second reviewer was consulted where inclusion 
or exclusion criteria could not be determined.   
 
Assessment of study quality 
A formal assessment of study quality was not performed as is recommended for a meta-
analysis (Pai, McCulloch et al. 2004).  The purpose of the present meta-analysis was to 
describe and estimate an effect from one night to the next among 9 PSG sleep variables 
within the same cohort.  Therefore, the randomisation process, group allocation, and 
method of blinding of the participants were irrelevant.  Moreover, the outcome 
measures were measured within the same individuals for all PSG variables.  As such, 
the primary research question did not fit a traditional randomised control trial, cross-
sectional, or case-control design.  Thus, the most appropriate appraisal on the quality of 
the studies is to consider the clinical homogeneity within each study population. 
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Data abstraction and coding 
Study and subject criteria were retrieved from each report independently by one author 
and tabulated.  Ambiguous data was resolved by discussion with a second reviewer.  
Items retrieved were: authorship, date of publication, number of subjects, gender 
distribution, and the following moderating factors: study population, sleep setting, 
recording montage, sleep period, scoring method, and the average age of the sample.  
Moderating factors were grouped as follows;  population as healthy sleepers, insomnia 
or depression; sleep setting as laboratory (hospital and sleep centre) or home; recording 
montage as either neuro (studies using only EEG, EOG, and EMG channels), full PSG 
(included the utility of respiratory and/or limb movement measures on both night), or 
switched (consisted of a full PSG on the first night, followed by only neuro channels on 
subsequent nights); sleep period as either ad libitum (allowed for habitual sleep 
periods), fixed (fixed timings), or unknown (did not report the available sleep period).  
The individual night 1 and night 2 data were coded in means and standard deviations 
(SD) for each sleep variable.  A pooled SD was computed by taking the root mean 
square of the night 1 and night 2 SD, and the standard error (SE) was recorded.   
 
Data synthesis and statistical analysis 
The mean difference (MD) for each sleep variable across the first two nights (N1 minus 
N2) and the SE were meta-analysed using MIX (Meta-analysis with Interactive 
eXplanations, Bax, Leon)(Bax, Yu et al. 2006; Bax, Yu et al. 2008).  Weighting was 
applied to each MD using the inverse variance method and the weighted mean 
difference (WMD) was calculated as a summary statistic to indicate the overall pooled 
MD among all included studies for each sleep variable.   Statistical significance was 
assessed using the Z statistic, computed by dividing the WMD by its SE, resulting in 
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the overall 95% confidence interval (CI) for each sleep variable.   Significance was met 
at an alpha level of p < 0.05.  Both fixed and random effects model assumptions were 
followed and reported as appropriate following the Q-statistic (the sum of squares of 
each MD about the WMD) to test for homogeneity and dispersion of the overall WMD 
for each sleep variable (Egger, Smith et al. 1997). The Q-statistic follows an 
approximate Chi-squared distribution on k-1 degrees of freedom, where k is the 
number of MDs under the null hypothesis that the true effect is the same for all trials.  
When Q is significantly lower than the chi-squared critical value, the null hypothesis is 
accepted; therefore the variability across the WMD does not exceed what would be 
expected by sampling error alone (fixed effects model).  A random effects model is 
reported when Q remains statistically large at p < 0.05, indicating poor homogeneity of 
the magnitude and direction of the WMD (Egger, Smith et al. 2001).  Accordingly, the 
I2 index was used as a second indicator of between-study (non-random) variance to 
quantify the extent of heterogeneity from the collection of WMD by comparing the Q 
statistic with its expected value assuming homogeneity (Higgins and Thompson 2002).  
Significance was assessed at I2 values between 30-60%, 50-90%, and 75-90%, as 
moderate, substantial, and considerably high heterogeneity, respectively (Higgins, 
Thompson et al. 2003). 
 
Step-wise exclusions were made for heterogeneous sleep variables to locate possible 
moderating factors (sleep setting, recording montage, and sleep period) influencing the 
FNE (Hedges and Olkin 1985).  An individual WMD for each group within a 
moderator was calculated using the appropriate fixed or random effects model and tests 
for homogeneity across groups were conducted (Qw).  The difference in the magnitude 
between each group WMD was determined using the Q between (Qb) statistic, where 
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the overall Q statistic is equal to the sum of the Qw and Qb.  Significance for Qb was 
met at an alpha level of p < 0.01 to minimise Type 1 error rate (Hedges and Olkin 
1985). 
 
The influence of age on the overall WMD for each sleep variables was analysed by 
plotting each individual study MD as a function of the average age.  The method of 
least squares was used to fit a linear equation.  The coefficient of determination (r2) was 
reported along with the proportion of variance (PVE% = r2 x 100) shared by the two 
variables, indicating the extent that age influences the WMD.   
 
Visual inspection of the individual sleep variable funnel plots (each MD versus the 
inverse standard error) was completed to identify significant outliers.  Publication bias 
was formally assessed by testing the degree of asymmetry according to the Egger test 
(Egger, Smith et al. 1997). 
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RESULTS 
 
Systematic Review 
The systematic search identified 120 studies of further interest.  An additional 38 
studies were included from a previous search (unpublished data).  After duplicates were 
removed there were a total of 83 studies identified for inspection of title and abstract 
for further consideration of inclusion.  Because the search terms used were broad but 
inclusive with respect to the FNE many studies identified were non-PSG ambulatory 
sleep recordings, or involved animals, pediatric patients, or patients with serious 
medical comorbidity.  Among the medical comorbidities were patients with sleep 
disordered breathing (Mosko, Dickel et al. 1988; Aber, Block et al. 1989; Redline, 
Tosteson et al. 1991), narcolepsy (Harsh, Peszka et al. 2000), epilepsy (Marzec, Selwa 
et al. 2005), nocturnal tumescence testing (Thase, Reynolds et al. 1987), post traumatic 
stress disorder (Ross, Ball et al. 1999), restless leg syndrome (Sforza and Haba-Rubio 
2005), psychiatric disorders otherwise not classified (Kupfer, Weiss et al. 1974), 
chronic fatigue syndrome (Le Bon, Minner et al. 2003), cystic fibrosis (Milross, Piper 
et al. 2002), and pregnant women (Brunner, Magdalena et al. 1994).  In addition, a 
number of studies cited using the FNE as a laboratory model for transient insomnia to 
evaluate various forms of treatment to improve sleep (Roehrs, Vogel et al. 1990; 
Erman, Loewy et al. 2004; Rosenberg, Caron et al. 2005; Suetsugi, Mizuki et al. 2007).  
Notably, two studies examined the phenomenon of readaptation to the sleep laboratory 
during long-term PSG studies (Schmidt and Kaelbling 1968; Schmidt and Kaelbling 
1971; Stepanski, Roehrs et al. 1981), and one study (Wohlgemuth, Edinger et al. 1999) 
evaluated the short-term stability of sleep parameters but each failed to meet the 
inclusion criteria (e.g., data were averaged).   
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Thus, a total of 45 were found to be relevant and short listed for further consideration.  
After review of abstracts and full-text papers where necessary, a total of 33 studies met 
our inclusion criteria and were retained. Figure 4.1 details the systematic search 
strategy.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.  Systematic literature search strategy.  This search resulted in a total of 33 studies 
involving healthy sleepers and patients with insomnia and depression.  Meta-analysis was 
completed for healthy sleepers only due to poor diagnostic homogeneity among the insomnia 
and depression study populations (n). 
Studies identified by systematic 
search 
(n = 120)  
Studies retrieved after duplicates removed 
(n = 84) 
Number of full-text articles assessed for eligibility 
(n = 49) 
Full-text articles excluded when data were from: 
after initial adaptation (n = 3) 
non-consecutive (n = 5) 
averaged for two nights (n = 2) 
from experimental designs (n = 4) 
subject with prior experience in testing (n = 2) 
Studies from previously 
unpublished search  
(n = 24) 
Studies included in literature review (n = 33)  
Studies included in meta-analysis (healthy sleepers) 
 (n = 24) 
Non relevant studies as data were from: 
non-PSG studies (n = 13) 
animals (n = 3) 
paediatric patients (n = 7) 
patients with medical comorbity (n = 12) 
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There were a total of 24 studies involving healthy individuals (Agnew, Webb et al. 
1966; Mendels and Hawkins 1967; Clausen, Sersen et al. 1974; Coble, McPartland et 
al. 1974; Johns and Dore 1978; Webb and Campbell 1979; Coates, George et al. 1981; 
Sharpley, Solomon et al. 1988; Kupfer, Frank et al. 1989; Wauquier, van Sweden et al. 
1991; Kayumov 1994; Toussaint, Luthringer et al. 1995; Woodward, Bliwise et al. 
1996; Zucconi, Ferini-Strambi et al. 1996; Rotenberg, Hadjez et al. 1997; Toussaint, 
Luthringer et al. 1997; Le Bon, Staner et al. 2001; Lorenzo and Barbanoj 2002; 
Riemann, Klein et al. 2002; Curcio, Ferrara et al. 2004; Heitkemper, Jarrett et al. 2005; 
Tamaki, Nittono et al. 2005; Feige, Scaal et al. 2007; Bolla, Lesage et al. 2008). 
 
There were 9 studies involving patients with insomnia (Coates, George et al. 1981; 
Hauri and Olmstead 1989; Edinger, Marsh et al. 1991; Toussaint, Luthringer et al. 
1995; Saletu, Klosch et al. 1996; Zucconi, Ferini-Strambi et al. 1996; Edinger, Fins et 
al. 1997; Toussaint, Luthringer et al. 2000; Riedel, Winfield et al. 2001). 
 
There were 6 studies involving patients with depression (Reynolds, Newton et al. 1982; 
Ansseau, Kupfer et al. 1985; Ansseau, Kupfer et al. 1985; Kupfer, Frank et al. 1989; 
Toussaint, Luthringer et al. 1995; Rotenberg, Hadjez et al. 1997). 
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Study quality (clinical homogeneity) 
The studies involving healthy individuals demonstrated clear clinically homogeneity.  
The diagnostic criteria for participant recruitment were measured according to common 
methodology.  In most studies, these criteria were the absence of self-reported 
significant medical and psychiatric comorbidity.  Other criteria included the use of a 
validated screening questionnaire (Coble, McPartland et al. 1974; Curcio, Ferrara et al. 
2004), drug screen (Toussaint, Luthringer et al. 1995; Toussaint, Luthringer et al. 1997) 
or structured clinical interview (Toussaint, Luthringer et al. 1995; Zucconi, Ferini-
Strambi et al. 1996; Toussaint, Luthringer et al. 1997; Toussaint, Luthringer et al. 
2000).  In one study healthy individuals also were asked to complete a survey to assess 
the anxiety related personality traits (Kajimura, Kato et al. 1998); these were either 
‘low’ or ‘high’ anxiety traits; thus the ‘high anxiety’ group was excluded.  Thus, there 
were only minimal differences and nearly all studies reportedly used a self-reported 
method to screen for diseased states. 
 
The studies involving patients with insomnia and depression demonstrated substantial 
clinical heterogeneity.  Although a structured or clinical interview was among the most 
common methodology used to diagnosis these conditions, insomnia has various sub-
types and the depressive episode varies in severity.  The clinical diagnosis of primary 
insomnia appropriately involved the assessment of the patients’ self-reported 
disturbance to sleep initiation and/or to sleep maintenance, or, a non-restorative sleep 
(Morin and Espie 2003).  However, most of the included studies did not report the 
insomnia sub-type.  One study reported patients were with mixed difficulties initiating 
and maintaining sleep (DIMS) (Edinger, Marsh et al. 1991) and another reported DIMS 
with generalized anxiety disorder (Saletu, Klosch et al. 1996).  Similarly, the 
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depressive episode can be variable and was appropriately assessed in most studies 
(Hamilton 1960).  However, a threshold or cut-off score was not commonly reported.  
Also, one study reported on inpatients in a hospital (Toussaint, Luthringer et al. 2000).  
Thus, these differences introduce clear clinical heterogeneity among the recruited 
patients with depression.  Therefore, a quantitative analysis was not conducted for both 
groups.  Instead, a qualitative summary is provided below. 
 
FNE in depression and insomnia  
There was no consensus regarding the presence or characteristics of the FNE in the 
studies involving patients with insomnia or depression.  It was noted in one study that a 
single night PSG may be inappropriate to fully convey the nature of a patient’s sleep 
disturbance (Edinger, Marsh et al. 1991).  Thus, the clinical populations do not 
manifest the FNE similarly to healthy sleepers.  In depression, an attenuated FNE was 
initially observed (Mendels and Hawkins 1967).  Moreover, most findings report a 
significant FNE for measures of REM sleep only (Reynolds, Newton et al. 1982; 
Ansseau, Kupfer et al. 1985; Rotenberg, Kayumov et al. 1997; Toussaint, Luthringer et 
al. 1998).   
 
Noteworthy among the reports in insomnia were studies showing a clear reversed FNE 
(RFNE) in which sleep is actually of better quality on the first night compared to a 
subsequent night (Hauri and Olmstead 1989; Riedel, Winfield et al. 2001).  The RFNE 
was characterised by a shorter SOL, reduced REML, and greater SE and TST.  Hauri & 
Olmstead (1989) suggested the maladaptive associations present in the home sleep 
environment do not generalise to the sleep laboratory and therefore an RFNE was 
present.  Given the sleep laboratory presents a stressful stimulus in healthy persons, it is 
 - 56 - 
likely there is a relationship between anxiety levels, insomnia, and the FNE.  Reidel & 
Winfield (2001) examined this relationship in older patients with insomnia.  The data 
indicated that elevated anxiety levels on PSG night 1 contributed to a FNE, but a 
considerably proportion of the insomnia patients still show a clear RFNE.  Hauri and 
Olmstead (1989) failed to identify any such difference in anxiety levels between the 
FNE and RFNE patient groups.  Thus, it is unknown to what extent anxiety levels 
contribute to the differential reports in insomnia.  Further research is needed to evaluate 
this differential response during the first two nights of PSG recording in these patient 
groups.  Thus, it remains largely unknown whether a single familiarisation night or 
multiple nights is needed to account for the FNE in clinical patients.   
 
Meta-Analysis 
Meta-analysis was completed in healthy sleepers only but not in the insomnia and 
depression group due to poor homogeneity among the clinical diagnostic criteria.  An 
abbreviated coding sheet showing non PSG study characteristics (author, year, sample 
size, moderating factors) of the included studies is reported in Table B1 (Appendix B).  
There were a total of 421 subjects (163 males, 201 females, 57 in mixed gender 
reports) included in the meta-analysis.  There were 19 studies (79%) conducted in the 
laboratory compared to 5 studies in the home.  A total of 13 studies used a neuro 
montage, 8 used a full PSG on both night, and 3 followed a switched montage.  The 
sleep period was provided ad libitum in 13 studies, fixed in seven studies, and 
unknown in the remaining four. 
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A total of 16 studies reported using the scoring guidelines of Retschaffen & Kales 
(Rechtschaffen and Kales 1968), 2 studies used the system of Dement & Kleitman 
(Dement and Kleitman 1957), 2 studies used the system of Agnew (Agnew, Webb et al. 
1966), one study used a validated auto scoring system (Sharpley, Solomon et al. 1988), 
and the other four did not report the scoring guidelines (Coble, McPartland et al. 1974; 
Johns and Dore 1978; Kayumov 1994; Zucconi, Ferini-Strambi et al. 1996). 
 
A summary of the WMD for each sleep variable, 95% CI, Q statistic, and significance 
level is reported in Table 4.1.  Two studies (Agnew, Webb et al. 1966; Mendels and 
Hawkins 1967) did not report a measure of variance therefore the median SD was used 
(Furukawa, Barbui et al. 2006)..  The cumulative forest plots (Figure 4.2) sorted by 
publication date for the 6 significant FNE sleep variables is presented on the following 
pages as a summary of the individual and cumulative data present above.  The 
individual study MD is represented by a point with respective 95% CI (horizontal line); 
the overall WMD is represented the diamond apex with 95% CI (diamond end points).   
 
The data confirm the FNE in healthy sleepers indicating on the first night compared to 
a subsequent night there is a prolonged SOL (4.46 min), a delayed REML (20.55 min), 
an increase in WASO (3.88%), and reductions in TST (-18.81 min), SE (-4.66%), 
REMS (-2.17%; all p < 0.01).  A trend was seen for a small but significant increase in 
NREM1 (0.84%, p = 0.07).   A random effects model was used for SOL, REML, TST, 
and SE (Q p < 0.05) indicating that factors other than the recording night may be 
responsible for the observed variability.  Between study variance (I
2
) remained 
considerably high for REML (89%), TST (88%), and SE (67%), and substantial for 
SOL (46%).   
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Table 4.1.  Summary of each WMD for PSG sleep variables of the FNE in healthy 
sleepers 
 
Sleep Variable k n WMD 95% CI Z Q I
2
 
SOL (min) 21 383 4.46 b 2.49 to 6.43 4.44* 37.29* 46% 
REML (min) 21 370 20.55 b 12.6 to 28.5 5.07* 177.1* 89% 
WASO (%TST) 17 337 3.88 a 2.74 to 5.03 6.64* 23.65 32% 
TST (min) 14 225 -18.81 b -28.55  to -9.06 3.78* 109.91* 88% 
SE (%) 17 264 -4.66 b -6.59 to -2.73 4.73* 42.2* 67% 
NREM1 (%TST) 17 274 0.84 a 0.06 to 1.73 1.83 8.52 0% 
NREM2 (%TST) 17 294 0.44 a -0.86 to 1.75 0.66 7.1 0% 
SWS (%TST) 19 318 -0.81 a -1.85 to -0.23 1.52 10.47 0% 
REMS (%TST) 20 326 -2.17 a -3.11 to -1.22 4.49* 9.07 0% 
K, number of studies; n, number of subjects; WMD, weighted mean difference; a, fixed effect 
model, b random effect model, * denotes p < 0.05. 
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Figure 4.2.  Forest plots of PSG sleep variables of the FNE in healthy sleepers.  These forest 
plots (sorted by publication date) representing individual study mean differences (points), their 
respective 95% CI (horizontal lines), and the overall weighted mean difference (diamond 
apex, line) and 95% CI (diamond end-points). 
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Figure 4.2 continued. Forest plots of PSG sleep variables of the FNE in healthy sleepers.  
These forest plots (sorted by publication date) representing individual study mean differences 
(points), their respective 95% CI (horizontal lines), and the overall weighted mean difference 
(diamond apex, line) and 95% CI (diamond end-points). 
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Figure 4.2 continued.  Forest plots of PSG sleep variables of the FNE in healthy sleepers.  
These forest plots (sorted by publication date) representing individual study mean differences 
(points), their respective 95% CI (horizontal lines), and the overall weighted mean difference 
(diamond apex, line) and 95% CI (diamond end-points). 
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Moderating Factors 
Sleep Setting 
The FNE was more pronounced during laboratory (prolonged SOL, delayed REML, 
increased WASO, and decreased TST, SE, and REMS) compared to the home (delayed 
REML, increased WASO, and reduced SE) as indicated by the greater number of 
WMD (Table 4.2).  The delayed REML in the laboratory (22.73 min) was greater (Qb 
6.83, p < 0.01) than in the home (11.36 min; both p < 0.05).  Significant heterogeneity 
was present in both locations, especially for TST (Q laboratory 23.33, home 81.78, 
both p < 0.05) and SE (Q laboratory 30.47, home 11.72, both p < 0.05).  Additional 
heterogeneity was indicated in the laboratory for SOL (Q = 30.30) and for REML (Q = 
157.89, both p < 0.05).  Other sources besides the sleep setting may be responsible for 
the substantial between study variance (I2) in the laboratory among REML (90%), TST 
(66%), and SE (70%), and in the home for TST (95%) and SE (66%). 
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Table 4.2.  Influence of the sleep setting on heterogeneous PSG sleep variables of the 
FNE in healthy sleepers 
 
Sleep Variable k WMD Q Qw Qb I
2 
SOL (min)     nil  
laboratory 16 5.06b* 30.3*   51% 
home 5 2.42a 5.09 p < 0.05  21% 
REML (min)     p < 0.01  
laboratory 17 22.73b* 167.89*   90% 
home 4 11.36a* 2.38 p < 0.01  0% 
WASO (%TST)     nil  
laboratory 13 4.54a* 18.69   36% 
home 4 2.31a* 1.96 p = 0.15  0% 
TST (min)     nil  
laboratory 9 -17.38b* 23.33*   66% 
home 5 -20.45b 81.78* p < 0.01  95% 
SE (%)     nil  
laboratory 12 -4.62b* 30.47*   70% 
home 5 -4.83b* 11.72* p < 0.05  66% 
REMS (%TST)     nil  
laboratory 16 -2.25a* 8.39   0% 
home 4 -1.78a 0.54 p = 0.96  0% 
K, number of studies; WMD, weighted mean difference; a fixed effect model, b random effect 
model; Q, Q statistic; Qw, Q within group; Qb, Q between groups;  I2, I2 statistic;  
* denotes p < 0.05. 
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Recording Montage 
The FNE was more pronounced when the neuro (prolonged SOL, delayed REML, 
increased WASO, and reduced TST, SE, and REMS) compared to the full PSG 
(prolonged SOL, delayed REML, increased WASO, and reduced SE and REMS) and 
switched montage was used (increased WASO) as indicated by the greater number of 
significant WMD (Table 4.3).  The delayed REML was greater (Qb p < 0.05) when the 
neuro (25.56 min) montage was used. Significant heterogeneity was present in all 
montages for REML, TST, and SE (Q statistics, Table 4.3).  Additional heterogeneity 
was present for the neuro montage for SOL (Q = SOL 20.72) and WASO (Q = 18.39; 
both p < 0.05).  Other sources besides the recording montage may explain the 
substantial between study variance (I2), especially for measures of REML, TST, and SE 
(all >73%) and to a moderate degree for WASO and SOL (both >30%, Table 4.3). 
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Table 4.3.  Influence of the recording montage on heterogeneous PSG sleep variables 
of the FNE in healthy sleepers  
 
Sleep Variable k WMD Q Qw Qb I
2 
SOL (min)     nil  
neuro 12 4.76b* 20.72*   47% 
full PSG 7 3.76a* 8.62   30% 
switched 3 2.79b 7.10 p < 0.01  72% 
REML (min)     p < 0.05  
neuro 11 25.56b* 128.14*   92% 
full PSG 7 16.07b* 29.25*   79% 
switched 3 13.22 10.6* p < 0.01  81% 
WASO (%)     nil  
neuro 10 4.71b* 18.39*   51% 
full PSG 4 2.85a* 4.10   0% 
switched 3 4.34a* 0.01 p < 0.05  0% 
TST (min)     nil  
neuro 9 -17.77b* 19.14*   58% 
full PSG 5 -20.10b 88.57*   95% 
switched 0   p < 0.01  73% 
SE (%)     nil  
neuro 8 -4.49b* 21.09*   72% 
full PSG 7 -4.47b* 18.88*   74% 
switched 2   p < 0.01   
REMS (%TST)     nil  
neuro 11 -2.12a* 3.33   0% 
full PSG 6 -2.23a* 5.60   29% 
switched 3 -1.38a 0.26 p = 0.98  0% 
K, number of studies; WMD, weighted mean difference; a fixed effect model, b random effect 
model; Q, Q statistic; Qw, Q within group; Qb, Q between groups;  I2, I2 statistic; * denotes p 
< 0.05.  neuro: studies using only EEG, EOG, and EMG channels; full PSG: included the 
utility of respiratory and/or limb movement measures on both nights; switched: consisted of a 
full PSG on the first night, followed by neuro channels on subsequent nights 
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Sleep Period 
The FNE was similar whether the sleep period was provided ad libitum or fixed 
(prolonged SOL, delayed REML, increased WASO, and decreased TST, SE, and 
REMS), but both were more pronounced than when the sleep period was unknown 
(increased WASO and decreased REMS) as indicated by the number of significant 
WMD (Table 4.4).  There were no significant differences across groups (all, Qb nil).  
Significant heterogeneity was present in all sleep periods for REML (Q ad libitum 
87.01, fixed 31.54, unknown 52.66, all p<0.05).  Additional heterogeneity was 
indicated when the sleep period was provided ad libitum for WASO (Q = 18.42), TST 
(Q = 78.46), and SE (Q = 28.81, all p < 0.05) or when the sleep period was unknown 
for TST (Q = 29.31), SE (Q = 9.30, both p < 0.05).  Between-study variance (I
2
) 
remained high for REML across all sleep periods, but was minimal when sleep period 
was fixed for the other six sleep parameters (Table 4.4).   
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Table 4.4.  Influence of the sleep period on heterogeneous PSG sleep variables of the 
FNE in healthy sleepers  
 
Sleep Variable k WMD Q Qw Qb I
2 
SOL (min)       
ad libitum 12 5.02a* 14.56   24% 
fixed 4 5.05a* 2.95   0% 
unknown 4 4.56b 14.15* p<0.01 nil 79% 
REML (min)       
ad libitum 11 22.24b* 87.01*   89% 
fixed 6 20.22b* 31.54*   84% 
unknown 4 16.90b 52.66* p<0.01 nil 94% 
WASO (%)       
ad libitum 10 3.69b* 18.42*   51% 
fixed 4 5.35a* 1.02   0% 
unknown 3 4.34a* 2.07 ns nil 3% 
TST (min)       
ad libitum 8 -19.83b* 78.46*   91% 
fixed 3 -21.8a* 1.65   0% 
unknown 3 -12.01b 29.31* p<0.01 nil 93% 
SE (%)       
ad libitum 9 -4.79b* 28.81*   75% 
fixed 4 -5.58a* 0.44   0% 
unknown 4 -3.79b 9.30* p<0.01 nil 78% 
REMS (%TST)       
ad libitum 9 -1.86a* 2.15   0% 
fixed 6 -2.37a* 5.6   11% 
unknown 5 -2.37a* 1.05 ns nil 0% 
K, number of studies; WMD, weighted mean difference; a fixed effect model, b random effect 
model; Q, Q statistic; Qw, Q within group; Qb, Q between groups;  I2, I2 statistic; * denotes p 
< 0.05. Ad libitum refers to a habitual sleep period, fixed refers to fixed research timing, and 
unknown refers to when the sleep period was not reported. 
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Age 
The average age of the study sample moderately contributed to the variance in FNE 
among the following sleep variables: TST (52%), SE (40%), and to a lesser but 
meaningful degree for SWS (21%), and SOL (15%).  The reduced TST (r2 = 0.52, p < 
0.005) and reduced SE (r2 = 0.40, p < 0.01) were negatively associated with increasing 
age (solid lines, Figure 4.3).  However, when the study by Waquier et al. (1992) was 
excluded as an outlier (mean age 85 y), the age-related trends were absolved; TST (r2 = 
0.09, p = 0.32) and SE (r2 = 0.17, p = 0.11).  Post-hoc comparison of age indicated that 
when an average age cutoff of 35 y was applied (younger, < 34.99 y vs. older, > 34.99 
y) there was a trend showing a decreased SWS among the older group only (WMD 
fixed effects, older -1.89%, p = 0.08).   
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Figure 4.3.  Age-related trends for PSG sleep variables of the FNE in healthy sleepers.  Age-
related trends (solid line) for the weighted mean difference of TST, SE, and SWS.  When an 
age-related outlier was removed for the study by Wauquier et al. 1992 (mean age 85 y) the 
age-related trends were absolved (dotted line). 
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Publication Bias 
Visual inspection of individual funnel plots (1/SE) showed outliers were present for 
REML, WASO, TST, and SE (Figure B1, Appendix B).  Formalised tests for 
asymmetry indicated significant publication bias for SE (intercept -3.65, p = 0.03) and 
WASO (intercept 3.92, p < 0.01), with a trend for REML (intercept 9.01, p = 0.06).  
Post-hoc analyses (for these 4 variables) were conducted to examine if a small sample 
size accurately explained the publication bias.  Sample size (n) was designated as small 
(n < 11; k = 11), medium (n = 12-20; k = 8), or large (n > 20; k = 6) where at least 3 
MDs were present.  The delayed SOL was limited to studies with medium and large 
samples only (WMD small, random effects, 2.69 min, p = 0.20; medium 5.05 min, 
large 5.71 min, both fixed effects, p < 0.05).  The reduced TST followed the same 
pattern (WMD small, random effects, -17.63 min, p = 0.14; medium, random effects, -
17.06 min; large, fixed effect, -19.93 min, both p < 0.01).  The delayed REML and 
decreased SE were present in all conditions; however the random effects model was 
used for studies with small sample sizes.   
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DISCUSSION 
 
To our knowledge this is the first meta-analysis to quantitatively confirm the FNE in 
healthy sleepers.  The utility of a meta-analysis to examine data from accumulated 
sleep reports has been shown elsewhere (Ohayon, Carsadon et al. 2004; Zhang and 
Wing 2006; Kobayashi, Boarts et al. 2007).  The FNE in healthy sleepers was 
characterised by a prolonged SOL, delayed REML, increased WASO, and reductions in 
REMS, TST, SE.   Among the moderating factors, differences in the sleep setting, but 
not the recording montage or sleep period, accounted for part of the variability.  
Further, publication bias contributed to part of the heterogeneity among measures of 
REML, WASO, and SE but age was not a major factor influencing the characteristics 
of the FNE.  
 
Noteworthy are the calculated weighted mean difference (WMD, Table 4.1) values for 
each sleep variable.  Each WMD provides a clear estimate for the magnitude and 
direction of the FNE in healthy sleeper.  The delayed SOL was small (4.46 min) and 
likely reflects a ceiling effect in healthy sleepers (Coble, McPartland et al. 1974).  
However, the importance of this finding during intervention studies where small 
changes to SOL are expected is noteworthy.  Although not empirically examined, 
differences in the application of scoring criteria for SOL remain a possible source of 
heterogeneity among sleep variables reflecting time domains (SOL, REML, TST, and 
SE). These findings point to the importance of implementing standardised scoring rules 
as presented in the American Academy of Sleep Medicine Manual (Iber, Ancoli-Israel 
et al. 2007).    However, the use of change scores (WMD) across nights minimised this 
confounding factor.  Further, one study which exclusively investigated the FNE on the 
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sleep onset period showed similar results using either the first occurrence of stage 1 or 
stage 2 as definitions of SOL (Tamaki, Nittono et al. 2005).  Along with the delayed 
SOL, the data indicate an increased WASO (3.88%) and considerable reduction to SE 
(-4.66%).  These factors may have contributed to the large reduction in TST (-18.81 
min).   
 
A prominent feature of the FNE is the disruptions to REM sleep.  The data indicated a 
marked delay in REML (20.55 min), reflecting all but two of the included studies 
(Kupfer, Frank et al. 1989; Bolla, Lesage et al. 2008).  Additionally, there was a 
significant, but small reduction in REMS overall (-2.17%, p < 0.01).  These 
characteristics of the FNE are likely explained by the tendency to miss the first and 
shortest REMS period during the first sleep cycle (Agnew, Webb et al. 1966; Mendels 
and Hawkins 1967; Webb and Campbell 1979; Toussaint, Luthringer et al. 1995; 
Toussaint, Luthringer et al. 1997).  The NREM sleep measures showed relative stability 
across nights evident by each WMD that was close to zero: NREM1 (0.84%), NREM2 
(0.44%), and SWS (-0.81%).  In the present study the use of a WMD could not be 
avoided but it may be misleading to estimate the change in NREM sleep across the first 
two nights.  The forest plots for NREM2 and SWS (Figure B2, Appendix B) show that 
each individual study MD is on either side of the zero axes and the corresponding 95% 
CI is large.  Thus, a WMD that is close to zero reflects very large differences in 
opposite directions.  Thus, it is equally likely that NREMS measures will show a 
relative increase or relative decrease across the first two consecutively recorded PSG 
studies. 
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The step-wise analysis using various methodological factors was warranted among 
measures of SOL, REML, TST, and SE given substantial between-study variance 
(Hedges and Olkin 1985).  The FNE was more pronounced in the sleep laboratory than 
in the home as indicated by the number of significant WMD (Table 4.2).  Indeed, there 
was a two-fold greater delay in REML in the sleep laboratory.  It remains unclear to 
what extent the recording montage affects the FNE.  The data indicate a stronger 
response in the neuro setting where only EEG and EOG signals were monitored, 
compared to a full PSG setup that was expected to contribute to more disruptions.  
Publication bias was evident, especially for REML, WASO, and SE as demonstrated by 
the tests for asymmetry (including post-hoc analysis). Thus, it is likely that those 
studies not reporting a significant FNE (Clausen, Sersen et al. 1974; Coble, McPartland 
et al. 1974; Coates, George et al. 1981; Wauquier, van Sweden et al. 1991; Zucconi, 
Ferini-Strambi et al. 1996) were underpowered. 
 
Limitations  
The present meta-analysis suffers from some limitations.   First, this study was unable 
to examine the interaction of two moderating factors at one time.  The resultant 
groupings would have been too small to provide meaningful interpretations.  Second, 
the analysis only reviewed measures of sleep macro architecture that were common to 
the FNE literature.  One study (Curcio, Ferrara et al. 2004) reviewed the impact of the 
FNE on quantitative EEG data (i.e., spectral analysis) which may be important during 
investigations of sleep micro structure.  Third, there are many potential moderating 
factors that could be examined such as the various other clinical groups (e.g. sleep 
apnea, PLMD).  With respect to gender influences, De Gennaro et al. (2002) reported a 
greater delay in REML and greater reduction in REMS in males compared to females 
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(De Gennaro, Ferrara et al. 2002) but this study was not included in the present analysis 
as it incorporated groupings of otherwise healthy subjects across personality factors.  
 
Future research 
There were various other topics addressed within the examined studies but these were 
outside the framework of the present study.  A prominent feature of the FNE in healthy 
sleepers is the disruption to REM sleep which may remain for periods up to three 
(Agnew, Webb et al. 1966; Mendels and Hawkins 1967; Schmidt and Kaelbling 1971; 
Webb and Campbell 1979; Toussaint, Luthringer et al. 1995; Toussaint, Luthringer et 
al. 1997) or four nights (Le Bon, Staner et al. 2001) suggesting a longer familiarisation 
period may be necessary.  This is of particular importance in research settings where 
changes to REMS are considered as part of the research question and especially when 
applied to clinical populations where altered REM sleep is often reported (Le Bon, 
Staner et al. 2001).  Unfortunately, as it was not a primary objective to examine the 
FNE extending past the second night there were insufficient study numbers to warrant 
additional analysis.     
 
Equally important, the impact of re-entry into the sleep laboratory during long-term 
experimental studies was examined.  Lorenzo et al. (2002) investigated the FNE across 
multiple sleep laboratory sessions, each lasting 4 consecutive nights.  The FNE was 
only present for the initial period described as the “very first night effect”.  These 
authors concluded that the first night PSG data after re-entry within a specific protocol 
need not be excluded before subsequent analysis in healthy sleepers (Lorenzo and 
Barbanoj 2002).   
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Finally, the conceptual theories for the presence of the FNE were reported.  The FNE is 
thought to represent a normal but heightened arousal response to a new stimulus, either 
that of the sleep laboratory (Agnew, Webb et al. 1966) or the sleep equipment itself 
(Mendels and Hawkins 1967).  Given the sleep laboratory and PSG recording can be 
considered a stressful response in healthy individuals, it was suggested the FNE reflects 
a miniature model of psychophysiological insomnia, in which sleep is characterised by 
increased vigilance (Curcio, Ferrara et al. 2004).  In fact, clinical studies investigating 
treatment efficacy on transient-type insomnia have incorporated the FNE into the study 
design as noted in the systematic search results.   Other studies have proposed that the 
FNE represents the age-related adaptability of the central nervous system given there 
were greater disturbances with increasing age (Wauquier, van Sweden et al. 1991; 
Toussaint, Luthringer et al. 1995).  These theoretical viewpoints, although likely 
substantiated, cannot be evaluated within the framework of the present analysis.   
 
Summary and application to PSG study design 
In summary, we believe this study was warranted and will serve as a valuable tool to 
aid in PSG study design.  This study provides quantitative data to substantiate the need 
to allow for at least 1 night for familiarisation during PSG studies.  Moreover, this 
study provides an estimate on the magnitude of observed changes to 9 PSG sleep 
variables across the first two consecutively recorded nights.  This has important 
implications not only in research involving healthy individuals, but also in clinical 
studies where a control group is mandatory. 
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CHAPTER 5.  Postprandial tryptophan availability after a high and low GI mixed 
macronutrient compared to a carbohydrate only meal 
 
The enclosed study at the time of writing this thesis was in review as follows: 
 
C.P. Herrera, K. Smith, F. Atkinson, P. Ruell, C.M. Chow, H. O’Connor, & J. Brand-
Miller (2010).  High glycemic index meals increase the availability of tryptophan in 
healthy volunteers.  In revision: British Journal of Nutrition: MS #: BJN-2010015521 
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ABSTRACT 
Introduction:  High GI carbohydrate ingestion results in a significantly elevated postprandial 
plasma TRP/LNAA concentration.  The TRP/LNAA concentration describes the availability 
of tryptophan to the brain where it is converted to serotonin, a neurotransmitter involved in 
sleep regulation.  It is largely unknown to what extent a mixed macronutrient meal will impact 
on TRP/LNAA concentrations compared to a carbohydrate only meal.   
 
Methods:  10 healthy males (22.9 ± 3.4 y, BMI 23.5 ± 1.6 kg.m-2) underwent GI testing.  
Postprandial glucose, insulin (both 2 h), and amino acid (4 h) responses to three test meals 
administered in random order: a carbohydrate only high GI (CHGI) and each of an 
isoenergetic mixed macronutrient high and low GI (MHGI, LHGI respectively) meal.  
ANOVA with a priori contrasts (two-factor, meal x time) were used to examine the 
postprandial TRP, LNAA, and TRP/LNAA responses.  The incremental area under the curve 
(AUC) was computed for the TRP/LNAA response.  Paired samples t-tests were used to 
compare the GI, GL, II, and AUC between meals.   
 
Results:  GI, GL, and II values were all significantly different between meals; the CHGI meal 
had the largest values followed by the MHGI and MLGI meals respectively.  Postprandial 
TRP concentration initially increased after the MHGI and MLGI meals but steadily declined 
after the CHGI meal.  Postprandial LNAA concentration declined after all meals but fell lower 
and more sharply after the CHGI meal (both comparisons, p < 0.05).  Postprandial plasma 
TRP/LNAA concentration peaked at 2 h after each meal (p < 0.05); corresponding percentage 
rise from baseline was approximately 23% (CHGI), 17% (MHGI), and 8% (MLGI).  The 
AUC after the CHGI meal was 3-fold greater than the MLGI meal and showed marginal 
statistical difference (p = 0.05); there were no differences between the CHGI and MHGI meals 
(p = 0.38) or between the MHGI and MLGI meals (p = 0.43). 
 
Discussion:  This study demonstrated that the postprandial TRP/LNAA response was dose-
dependent of the GL values.  It is likely the GL may be useful to predict the postprandial 
TRP/LNAA response to mixed macronutrient meals.  These data confirm the underlying 
mechanism for improvements to sleep initiation after the CHGI meal in healthy individuals.  
Importantly, the MHGI meal represents a more balanced meal than the carbohydrate only 
meal. But the efficacy to improve sleep onset remains unknown.   
 
Keywords: glycemic index, glycemic load, tryptophan, amino acids, carbohydrate  
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INTRODUCTION 
 
The postprandial concentration of tryptophan (TRP) in the brain importantly dictates 
the synthesis of central nervous system serotonin (Spring 1984), a key neurotransmitter 
involved in the regulation of satiety (Lawton, Wales et al. 1995), mood (Orosco, Rouch 
et al. 2002), and sleep (Siegel 2004).  The availability of dietary TRP to the brain 
depends on its concentration relative to other large neutral amino acids (LNAA) which 
compete for a common transport molecule across the blood brain barrier (Wurtman, 
Hefti et al. 1981).  Dietary carbohydrate (CHO) promotes insulin secretion which 
enhances peripheral, skeletal muscle uptake of LNAA, except for TRP which is largely 
albumin bound.  This cascade of peripheral events results is a relatively higher plasma 
TRP/LNAA concentration (McMenamy and Oncley 1958).  Postprandial TRP/LNAA 
levels after predominately CHO ingestion range from an approximate 20-50% increase 
from baseline levels (Lieberman, Caballero et al. 1986; Lyons and Truswell 1988; 
Wurtman, Wurtman et al. 2003).  These findings indicate the postprandial TRP/LNAA 
response to CHO based meals is largely dependent of the glycemic index (GI).  
Ingestion of a high compared to a low glycemic index (GI) CHO food promotes greater 
insulin release and a larger postprandial rise in the plasma concentration of TRP/LNAA 
(Lyons and Truswell 1988).   
 
Recently, the GI of ingested CHO was shown to significantly influence sleep onset in 
healthy sleepers.  Afaghi et al. (2007) reported a 50% reduction in the time required to 
fall asleep after a CHO rich high GI compared to an isoenergetic low GI meal when 
consumed 4 h before bedtime in healthy men with normal sleep patterns (Afaghi, 
O'Connor et al. 2007).  Although not measured in this study, this was most likely due to 
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greater plasma insulin secretion and an increased plasma TRP/LNAA concentration 
after consumption of the high GI CHO rich meal.  
 
The effect of the GI of regular mixed macronutrient meals with a mixed macronutrient 
profile on the postprandial TRP/LNAA levels is largely unknown.  Addition of fat to a 
meal retards gastric emptying (Wells and Read 1995) and lowers the peak glycemic 
response (Ercan, Gannon et al. 1994) therefore insulin secretion would be decreased.  
Thus, addition of fat to a meal lowers the postprandial TRP/LNAA response (Lyons 
and Truswell 1988).  Moreover, protein ingestion contributes to increased dietary 
amino acids.  It has been suggested that the proportion of high GI CHO to protein of 
approximately 5:1 would neither raise nor lower the plasma LNAA concentration in 
humans because the direct contribution of LNAA from the added protein would be 
matched by the LNAA-lowering effect of insulin as a result of the CHO source (Berry, 
Growdon et al. 1991).    
 
Therefore, the aim of this study was to measure the postprandial glycemic, insulin, and 
amino acid responses of two isoenergetic high and low GI mixed macronutrient (MHGI 
and MLGI) meals compared to a CHO only (CHGI) meal.  The study hypothesis was 
that the MHGI meal will result in a greater postprandial rise in the plasma TRP/LNAA 
concentration compared to the MLGI meal and that both responses would be less than 
the CHGI meal.   
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METHODS 
 
Participants 
Ten healthy, young (22.9 ± 3.4 y), mixed ethnicity men of normal weight (BMI 23.5 ± 
1.6 kg.m-2) were recruited from a university student population.  Exclusion criteria 
included self-reported current or past history of medical, psychiatric or sleep disorders, 
current use of prescribed medication, recreational drug use, allergy related to the study 
protocol, or habitual use of a limiting/restrictive diet.  The study was approved by the 
Human Research Ethics Committee of The University of Sydney (Appendix C) and 
participants provided written informed consent (Appendix E) prior to participation. 
 
Meals 
Energy and macronutrient composition of the three test meals, carbohydrate only high 
GI (CHGI), mixed macronutrient high GI (MHGI) and mixed macronutrient low GI 
(MLGI), is summarised in Table 5.1.  The CHGI meal (3212 kJ) was replicated from a 
previous study (Afaghi, O'Connor et al. 2007) and consisted of a large portion of rice 
(Jasmine GI ~ 109, Riviana Foods, Sydney, Australia) served with a tomato based 
vegetable puree.  The mixed macronutrient meals (MHGI, MLGI) were isoenergetic 
(~1915 kJ), and consisted of  rice  (MHGI: Jasmine GI ~ 109; MLGI: Doongara GI ~ 
46; Riviana Foods) served with a sachet of Sundried Tomato Chicken (Lean CuisineTM, 
Nestle Australia Ltd; 965 kJ, 7.9 g fat, 14.1 g protein, 24.7 g CHO).  Meals were 
prepared in the University of Sydney Human Nutrition Unit kitchens.  Uncooked rice 
(raw weight of CHGI: 200 g; MHGI: 64.7 g; MLGI: 64.5 g) was prepared using an 
electric rice cooker prior to the testing day with a ratio of rice to water of 1:1.5.  
Cooked rice was frozen (-20oC) in individual portions and reheated in a microwave 
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prior to serving.  Frozen Lean Cuisine
TM
 sachets were heated in the microwave 
according to manufacturer recommendations and poured over the rice immediately 
prior to serving.  All meals were presented to participants with 250 mL of cool tap 
water and consumed within 15 min. 
 
Table 5.1.  Energy and macronutrient composition of the CHGI, MHGI, and MLGI meals   
 
Meal kJ 
Fat g 
(% energy) 
Protein g 
(% energy) 
CHO g 
(% energy) 
GI 
(GL) 
CHGI$ 
 
3212 
 
0.4 
(1.6%) 
16.8 
(8%) 
171.4 
(90.4%) 
117 
(200) 
MHGI 
 
1916 
 
7.9 
(16.2%) 
18.2 
(17.2%) 
75 
(66.6%) 
79 
(59) 
MLGI 
 
1913 
 
7.9 
(16.1%) 
18.6 
(17.5%) 
75 
(66.4%) 
51 
(38) 
All values expressed as mean.  GI calculated from glucose area-under-curve (AUC) data; GL 
calculated by multiplying the GI by the amount of available carbohydrate (g) in each food. 
$ Indicates the GI for the CHGI meal was approximate due to larger CHO content of this test 
meal compare to the reference glucose drink providing 75 g CHO (Brouns 2005).  It was 
determined unethical to use a glucose reference drink of 171.4 g CHO.  Abbreviations: CHGI, 
carbohydrate only high GI; MHGI, mixed macronutrient high GI; MLGI, mixed macronutrient 
low GI meals. 
 
 
 
 
 
 
 
 - 82 - 
Procedure 
Participants presented in the morning by at least 10 am, having fasted overnight for a 
period of at least 8 h.  Participants were required to avoid vigorous exercise for at least 
24 h prior to testing, abstain from alcohol (within 48 h), and avoid over or under eating.  
Smokers were advised to abstain on the morning before testing.  Participants were 
instructed to consume a high CHO, low fat evening meal devoid of legumes the night 
before each test session to avoid extreme hunger and variation in basal blood glucose 
concentration.  Self-reported compliance with these instructions was evaluated by a 
researcher (CH & KS) each morning prior to testing. 
 
Participants initially completed three, separate, reference tests at least 48 h apart using a 
glucose standard drink (77.1 g GlucodinTM powder, dissolved in 250 g of cold water; 
75 g available CHO) to calculate average glucose and insulin response.  A 75 g glucose 
load was used instead of a typical 50 g test load to appropriately calculate the GI of the 
MHGI and MLGI meals, which both provided 75 g of CHO (Chapter 3).  Test meals 
were administered in a randomised and counterbalanced order at least 48 h apart.  
Participants were blinded to the GI of the MHGI and MLGI meals which were identical 
in appearance.  A questionnaire comprising multiple 10cm visual analogue scales 
(VAS) was administered immediately after meal consumption to assess palatability (0 = 
poor taste, 10 = good taste), satiety (0 = still hungry, 10 = completely full), and 
participant sleepiness (0 = alert, 10 = sleepy (Appendix F). 
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Calculation of Glycemic Index (GI), Insulin Index (II), and Glycemic Load (GL)  
GI and II were calculated according to published guidelines (Brouns, Bjorck et al. 
2005) using the mean data from the participants and the following ratio;  the 120 min 
incremental area under the curve (AUC) of test meal compared to the mean AUC from 
the reference food multiplied by 100.  The GL was calculated using the equation, GL = 
(GI/100) x g available CHO.   
 
Biochemical Analysis 
Finger-prick blood samples were collected into separate eppendorf tubes at baseline (5 
min and 1 min prior to meal consumption) and after 15, 30, 45, 60, 90 and 120 min for 
analysis of glucose (Hitachi 912 automatic analyser, Boehringer Mannheim) and insulin 
(solid-phase antibody-coated tube radioimmunoassay, ‘Coat-A-Count’ Insulin RIA kit, 
Diagnostic Products Corporation, Los Angeles, CA, USA).  All samples were 
immediately centrifuged at 7900 rpm for 45 s, with plasma stored at -20oC for 
subsequent analysis.   
 
After test meals, but not reference test, additional (2 mL) blood samples were collected 
by venepuncture from a forearm vein into a lithium-heparinised tube at 0 (baseline), 
120, 180, and 240 min and immediately centrifuged (2500 rpm for 15 min at 40C) to 
separate plasma for subsequent analysis of amino acids: TRP and five LNAA (valine, 
leucine, isoleucine, phenylalanine, tyrosine) to calculate the TRP/LNAA ratio 
(McMenamy and Oncley 1958).  Plasma samples were collected into separate 
eppendorf tubes and stored at -800C until analysis by reverse phase high performance 
liquid chromatography (HPLC, Shimadzu).  All samples were analysed in duplicate 
following established methodology (Huq, Thompson et al. 1993).   
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Statistics  
Data are reported as means ± one standard deviation (SD).  All data were tested for 
normality of distribution and statistical procedures were completed using SPSS for 
Windows (SPSS Inc, version 15.0, Cary, NC, USA).  Student’s paired samples t-tests 
were used to identify differences between meals in palatability, satiety and sleepiness 
(VAS), the GI, GL, II, and the AUC of the TRP/LNAA response.   A two-factor (meal 
x time), repeated measures analysis of variance (ANOVA) was used to test for the 
postprandial effect of time post meal, meal type, and  interaction on TRP, LNAA, and 
TRP/LNAA concentrations.  In ANOVA, normality was satisfied using Mauchly’s test 
of sphericity unless reported with Greenhouse-Geisser value.  Significance was set at p 
< 0.05.   
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RESULTS 
 
Palatability, satiety, and sleepiness (VAS) 
Ratings for palatability after the MHGI and MLGI meals were almost identical with 
mean positive scores (favouring good taste) of 8.3 ± 1.4 cm and 8.3 ± 1.4 cm, 
respectively; p = 0.96).  Both mixed macronutrient meals were significantly more 
palatable than the CHGI meal (3.2 ± 2.2 cm; p < 0.001 for both comparisons).  Satiety 
was slightly higher after the MHGI meal (6.2 ± 1.6 cm) compared to the MLGI meal 
(4.9 ± 2.4 cm) but this difference was not statistically different (p = 0.05).  These 
ratings were significantly lower than after the CHGI meal (8.7 ± 1.1 cm, both 
comparisons, p < 0.001).  There were no statistical differences between sleepiness 
ratings assessed immediately after each meal (CHGI 6.2 ± 1.7; MHGI 5.6 ± 1.9; MLGI 
4.8 ± 2.4, all p > 0.05).   
 
Glycemic Index (GI), Glycemic Load (G), and Insulin Index (II) 
Data were omitted from one participant due to an abnormal fasting glucose 
concentration (Brouns, Bjorck et al. 2005).  Postprandial levels for blood glucose and 
insulin are shown in Figure 5.1.  A summary of the GI, GL, and II values is shown in 
Figure 5.2.   
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Figure 5.1. Postprandial glucose and insulin responses after the CHGI, MHGI, and MLGI 
meals in healthy participants.  Postprandial glucose was maximal at 30 min in all meal 
conditions before steadily declining to levels slightly above baseline at 120 min.  Postprandial 
insulin peaked at approximately 45 min after CHGI and MHGI but at approximately 60 min 
after MLGI followed by a gradual reduction. CHGI, carbohydrate only high GI; MHGI, mixed 
macronutrient high GI; MLGI, mixed macronutrient low GI.   
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Figure 5.2.  Summary of GI, GL, and II values for the CHGI, MHGI, and MLGI meals.  The 
corresponding measures in each meal condition were statistically different from one another 
(all p < 0.05).  CHGI, carbohydrate only high GI; MHGI, mixed macronutrient high GI; 
MLGI, mixed macronutrient low GI.   
 
GI, GL, and II values were all significantly different between meals; the CHGI meal 
had the largest values followed by the MHGI and MLGI meals respectively (all 
comparisons p < 0.05; Figure 5.2).  The GI value was greatest after the CHGI meal 
(116.6 ± 30.1), followed by the MHGI meal (78.6 ± 17.8), and the MLGI meal (50.8 ± 
20.4) respectively. The GI for the CHGI meal was approximate as it was determined 
unethical to use a glucose reference drink of 171.4 g CHO.  Calculated GL values were 
clinically different (Brand-Miller 2009) comparing the CHGI meal (~200), MHGI 
(58.9), and MLGI meals (38.2).  The II value was greatest after the CHGI meal (158 ± 
59.9), followed by the MHGI meal (81.9 ± 37.2), and the MLGI meal (55.7 ± 25.6) 
respectively.   
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Amino acid concentrations  
Analysis of amino acid was completed on seven participants; two participants failed to 
complete all venepuncture procedures.  Postprandial TRP and LNAA responses are 
shown in Figure 5.3.  Basal TRP and LNAA concentrations were not statistically 
different between meals.  TRP concentration after MHGI and MLGI were initially 
elevated compared to basal levels at 120 min (p = 0.02) and 180 min (p < 0.001) before 
declining, whereas TRP concentration after the CHGI meal showed a steady decline 
(time; F (1.2,7.4) = 7.2, p = 0.026 Greenhouse-Geisser).  There was a significant 
postprandial decline in LNAA concentration throughout the study period (time; F 
(3,18) = 43.2, p < 0.001).  The decline after the CHGI meal was significantly greater 
than after the MLGI (p = 0.04).  The rate of change in LNAA concentration between 
meals was significantly different (meal x time; F (6,36) = 8.7, p < 0.01).  The decline in 
LNAA concentration after the CHGI meal was more rapid than after both the MLGI (p 
= 0.001) and MHGI meals (p = 0.004).  
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Figure 5.3. Effects of the CHGI, MHGI, and MLGI on postprandial TRP and LNAA levels in 
healthy participants.  Postprandial TRP steadily decreased after CHGI but showed a relative 
increase at 120 min after both HGI and LGI before declining to near baseline.  Postprandial 
LNAA concentrations dropped after CHGI and HGI but showed a relative increased at 120 
min after MLGI before declining.  CHGI, carbohydrate only high GI; MHGI, mixed 
macronutrient high GI; MLGI, mixed macronutrient low GI.   
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The postprandial TRP/LNAA response is shown in Figure 5.4 and the concentration 
values are indicated in Table 5.2.  Basal TRP/LNAA concentrations were not 
statistically different between meals.  Postprandial concentrations were significantly 
elevated after all meals (time; F (1.7,10.0) = 17.3, p = 0.001 Greenhouse-Geisser); 
corresponding percentage rise from baseline was approximately 23% (CHGI), 17% 
(MHGI), and 8% (MLGI).  The AUC was greatest after the CHGI meal (4.4 ± 2.6), 
followed by the MHGI (2.8 ± 3.7) and MLGI meal (1.4 ± 1.4) but these differences 
were not statistically significant. There was a strong tendency for the AUC after the 
CHGI meal to be greater than the MLGI meal (p = 0.05).  The AUC data were not 
statistically different between the CHGI and the MHGI meals (p = 0.38) or between the 
MHGI and MLGI meals (p = 0.43). 
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Figure 5.4. Effects of the CHGI, MHGI, and MLGI on postprandial TRP/LNAA levels in 
healthy participants.  There was a significant postprandial rise after each test meal with a peak 
percentage increase between 180 and 240 min after meal consumption.  The corresponding 
peak percentage rise was approximately 23% after CHGI, 17% after MHGI, and 7% after 
MLGI.  CHGI, carbohydrate only high GI; MHGI, mixed macronutrient high GI; MLGI, 
mixed macronutrient low GI.   
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Table 5.2.  Mean postprandial LNAA and TRP/LNAA concentrations after the CHGI, MHGI, 
and MLGI meals in healthy participants 
 
  val ile leu trp phe tyr TRP/LNAA 
 Meal mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L 
CHGI        
0 min 244 ± 34 76 ± 9 140 ± 14 64 ± 9 57 ± 4 76 ± 13 0.1077 ± 0.014 
120 min 217 ± 22 50 ± 6 93 ± 11 63 ± 8 51 ± 3 68 ± 10 0.1328 ± 0.022 
180 min 216 ± 29 46 ± 2 88 ± 7 61 ± 9 51 ± 5 67 ± 13 0.1308 ± 0.020 
240 min 204 ± 23 42 ± 5 83 ± 10 58 ± 7 47 ± 3 63 ± 9 0.1326 ± 0.018 
MHGI        
0 min 234 ± 35 66 ± 13 133 ± 22 59 ± 7 54 ± 6 72 ± 16 0.1075 ± 0.022 
120 min 237 ± 28 69 ± 7 125 ± 10 67 ± 11 55 ± 5 73 ± 17 0.1215 ± 0.020 
180 min 230 ± 25 63 ± 8 116 ± 9 65 ± 11 51 ± 7 69 ± 18 0.1235 ± 0.020 
240 min 225 ± 28 61 ± 6 116 ± 14 61 ± 9 49 ± 6 65 ± 16 0.1198 ± 0.019 
MLGI        
0 min 230 ± 25 66 ± 11 132 ± 11 66 ± 5 57 ± 4 74 ± 15 0.1179 ± 0.009 
120 min 243 ± 24 76 ± 10 136 ± 10 73 ± 9 58 ± 4 78 ± 16 0.1233 ± 0.016 
180 min 235 ± 17 68 ± 8 123 ± 9 70 ± 7 55 ± 5 73 ± 14 0.1269 ± 0.015 
240 min 216 ± 23 59 ± 10 111 ± 9 63 ± 6 49 ± 5 67 ± 15 0.1255 ± 0.012 
Values are mean ± sd.  LNAA are as follows: valine (val), isoleucine (ile), leucine (leu), 
trptophan (trp), phenylalanine (phe), tyrosine (tyr).  CHGI, carbohydrate only high GI; MHGI, 
mixed macronutrient high GI; MLGI, mixed macronutrient low GI.   
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DISCUSSION 
 
This study was conducted to examine the biochemical responses leading to an 
increased postprandial availability of tryptophan after an isoenergetic high and low GI 
mixed macronutrient meal compared to a CHO only high GI meal.  The macronutrient 
profile and energetic load (kJ), after the MHGI and MLGI meals were improved 
compared to the CHGI meal.  The postprandial glycemic and insulin responses after the 
MHGI and MLGI meals were substantially reduced compared to the CHGI meal.  In 
addition, plasma TRP levels after the MHGI and MLGI meals were initially increased 
contrasting a steady decline after the CHGI meal.  The plasma LNAA levels were 
significant reduced after all meals, however plasma LNAA concentration dropped 
lower and more quickly after the CHGI meal compared to the MHGI and MLGI meals.  
The magnitude of the corresponding postprandial increase in the plasma TRP/LNAA 
responses was greatest after the CHGI meal, followed by the MHGI, and MLGI meals 
respectively.   
 
The MHGI and MLGI meals were identical in macronutrient composition and 
demonstrate improvement from the CHO only CHGI meal (Table 5.1).  Palatability 
ratings for the MHGI and MLGI meals were similar and favoured a good taste whereas 
ratings after the CHGI meal were below average.  The validity of VAS scales to assess 
subjective ratings of palatability after meal consumption is well established (Flint, 
Raben et al. 2000; Rahemtulla, Baldwin et al. 2005).  The mixed macronutrient 
composition of these meals with a relative energy contribution (~ 1915 kJ) is more 
closely representative of a typical adult meal and consistent with westernised dietary 
guidelines (Australia 2003; America 2005).   
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It has been reported that regular consumption the CHGI meal (with GL 175) would 
elicit potentially damaging postprandial glucose and insulin responses for those at risk 
for diabetes or obesity (Jenkins, Kendall et al. 2000; Pawlak, Ebbeling et al. 2002; 
Livesey 2005).  The lowered glycemic and insulin responses after the MHGI and MLGI 
meals compared to the CHGI meal carry important metabolic significance regarding the 
potential for regular meal consumption.  Although, the GL of the MHGI (59) and the 
MLGI (38) are still greater than the recommended high GL value for an individual meal 
(20), each is considerably below the recommended total daily high GL value (120) 
(Brand-Miller).  Thus, compared to the CHGI meal, the MHGI and MLGI are more 
suitable for regular consumption.  Further, given the meals were identical in 
appearance, future blinding during experimental studies would be easily achieved.  
 
Noteworthy are the individual TRP and LNAA responses between the mixed 
macronutrient meals and the CHGI meal.  Postprandial TRP concentration after the 
MHGI and MLGI meals was initially increased contrasting a steady postprandial 
decline after the CHGI meal (Figure 5.3).  The responses of the MHGI and MLGI 
meals mimic data reported in after a 500 kCal CHO and TRP (400 mg) evening meal 
(Ashley, Barclay et al. 1982).  Compared to the CHGI meal, the mixed macronutrient 
meals contributed to a higher level of TRP derived from a dietary protein source (e.g. 
chicken breast)(Harada, Hirotani et al. 2007).  Dietary TRP is largely albumin bound 
and therefore the presence of insulin does not promote significant skeletal muscle 
uptake (McMenamy and Oncley 1958).  Thus, the MHGI and MLGI meals provided a 
greater amount of albumin bound TRP compared to the CHGI meal, which resulted in a 
differential TRP response. 
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The rate of LNAA uptake after the CHGI meal was significantly greater than both the 
MHGI and MLGI meals.  Given the CHO:protein ratio was identical for the MHGI and 
MLGI meals (~ 4:1), the significant postprandial decline in LNAA concentration after 
the MHGI and MLGI meals is in direct contrast to the predicted nil postprandial LNAA 
response presented earlier (Berry, Growdon et al. 1991).  In addition, after the MHGI 
meal plasma LNAA levels steadily declined compared an initial rise after the MLGI 
meal (Figure 5.3).  The available amount of CHO in the CHGI meal (171.4 g) was 
markedly greater than both the MHGI and MLGI meals (each 75 g).  By using a high 
GI rice (Jasmine GI ~ 109) for the CHGI and MHGI meals, and a low GI rice 
(Doongara GI ~ 46) for the MLGI meal, the resulting meal GI and GL values were 
significantly different (Table 5.1).  This resulted in marked differences in the 
postprandial insulin response.  The release of insulin (II value) was greatest after the 
CHGI meal, followed by the MHGI and MLGI meal respectively (Figure 5.2).  These 
findings indicate the type and amount of CHO used in each meal substantially 
influenced the postprandial LNAA response.  Thus, the GL value is critical in 
consideration of postprandial LNAA concentration given it reflects both the type and 
amount of CHO in a meal (Chapter 3).  Indeed, at least in healthy sleepers, the GL is a 
reliable measure of the overall glycemic and insulin demand (Brand-Miller, Thomas et 
al. 2003). 
 
The magnitude of the postprandial rise in plasma TRP/LNAA concentration was 
similar to the magnitude of LNAA update.  The approximate percentage rise from 
baseline was greatest after the CHGI meal (23%), followed by the MHGI meal (17%) 
and the MLGI meal (7%; Figure 5.4).  These findings are in accordance with previously 
published data (Lieberman, Caballero et al. 1986; Lyons and Truswell 1988; Wurtman, 
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Wurtman et al. 2003).  Lyons & Truswell (1988) made the suggestion that the 
postprandial TRP/LNAA response will be greater after a high GI compared to a low GI 
food however GI testing was not completed.  The present results further this claim and 
indicate the GL is indeed a more reliable indicator of postprandial plasma TRP/LNAA 
levels.  In theory, if the MLGI meal was eaten as a double portion (~ 3826 kJ) it would 
have provided a substantially increased energy load, but the GI value will remain the 
same (Chapter 3).  On the other hand, by doubling the CHO content (to 150 g), the GL 
would have increase nearly 1.5 fold (GL ~ 77), which would have surpassed the GL 
value for the MHGI meal.  Therefore, this theoretical double-portion of the MLGI meal 
would likely result in a larger postprandial insulin demand and therefore also a greater 
rise in the plasma TRP/LNAA concentration.  Thus, we suggest the GL may be valid as 
a tool to predict the postprandial TRP/LNAA response to mixed macronutrient meals, 
but this remains untested. 
 
The availability of dietary TRP to the brain indicated by the plasma concentration of 
TPR/LNAA is known to increase central serotonin production in healthy individuals 
(Blum, Vered et al. 1992).  Further, the findings from Lyons and Truswell (1998) 
indicate the postprandial rise in plasma TRP/LNAA after CHO based meals is similar 
when consumed in the morning and in the evening prior to bedtime.  In a separate 
study, when the present CHGI meal was administered 4 h before the usual bedtime in 
healthy sleepers, sleep initiation was improved compared to an isoenergetic low GI 
version (Afaghi et al., 2007).  It was proposed that the efficacy of the high GI CHO 
meal to improve sleep was mediated via increased serotonin production and would be 
indicated by an increased plasma TRP/LNAA level, although amino acid 
concentrations were not measured.  The present data provide evidence to confirm the 
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suggested underlying mechanism demonstrating a marked rise in the TRP/LNAA after 
the CHGI meal.  Although serotonin was not measured in the present study, insulin 
reached maximal levels from baseline between 45-60 min after meal consumption.  The 
corresponding increases from basal levels after the CHGI meal (650%) and after the 
MHGI meal (450%) are consistent with published data to support increased serotonin 
production in healthy persons.  Blum et al. (1992) reported a 461% peak rise in 
postprandial insulin and an approximate 4-fold increase in platelet poor serotonin after 
ingestion of a CHO rich snack (200 kCal).  It may be speculated that the high insulin 
response observed for the CHGI meal and MHGI meals may similarly yield an increase 
in serotonin and therefore has the potential to alter sleep initiation. 
 
This study is not without limitation.  Subjective mood and alertness could have been 
assessed throughout the 4 h study period to provide more meaningful data on the 
effects of each meal on sleep initiation.  The venepuncture procedure for blood 
collection was a major methodological limitation and 2 participants were unable to 
complete the procedure.  Consequently, the biochemical data were limited by a low 
statistical power.  Because of the time course of glycemic testing, it was not feasible to 
include additional samples.  To minimise this risk in the future, blood collections could 
be made using an indwelling cannula.  Finally, the participants were all healthy, young, 
male adults therefore it is unknown to what extent gender may influence the 
postprandial TRP/LNAA response to these meals.  Recent evidence suggests the GL 
may be more relevant to women than men with respect to weight loss (McMillan-Price, 
Petocz et al. 2006), however, whether these findings relate to postprandial TRP/LNAA 
levels or changes in sleep behaviour remain untested. 
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In summary, the study results support a substantial dose-response effect of the GL of 
mixed macronutrient meals on the postprandial rise in the plasma TRP/LNAA 
concentration.  It is likely the GL may be useful to predict the postprandial TRP/LNAA 
response to mixed macronutrient meals.  Further testing is needed on the efficacy of the 
MHGI meal to improve sleep onset when served as an evening meal.  Future studies 
should include postprandial measurement of serotonin to elucidate the link between the 
postprandial glycemic responses and sleep onset.   
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CHAPTER 6: Efficacy of a high glycemic index (GI) compared to an isoenergetic 
low GI mixed macronutrient meal to improve sleep quality in insomnia.   
 
The enclosed study at the time of writing this thesis was presented as follows: 
 
C.P Herrera, P. Ruell, H. O’Connor, C.M. Chow (2010).  Influence of the glycemic 
load (GL) on subjective and objective measures of sleep quality in sleep initiation 
insomnia.  International Journal of Psychophysiology 77(3), p. 292. 
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ABSTRACT 
 
Introduction:  Insomnia is a pervasive sleep disturbance limiting sleep quality.  There is 
evidence in healthy sleepers to suggest sleepiness will increase after ingestion of large 
carbohydrate (CHO) meals.  The glycemic index (GI) of CHO is thought to play a role in sleep 
initiation given the availability of tryptophan to the brain is promoted after high GI foods.  
Evidence is lacking regarding the efficacy of the GI of regular meals to promote sleep 
initiation in participants with insomnia.  This study evaluates the efficacy of a mixed 
macronutrient high GI (MHGI) meal compared to a mixed macronutrient low GI (MLGI) meal 
to improve sleep quality in participants with insomnia. 
 
Methods:  Subjective and PSG sleep were assessed on 2 consecutive nights in a repeated 
measures, single blind study. Participants (4 men, 4 women) meeting research diagnostic 
criteria for insomnia were randomised to either the MHGI or MLGI meal.  Biochemical 
measurement of postprandial glucose, insulin, plasma tryptophan relative to other large neutral 
amino acids (TRP/LNAA), and platelet poor plasma serotonin (PPP-5HT) was completed and 
compared between meals using paired samples t-tests. 
 
Results:  The MHGI meal resulted in improved subjective, but not PSG sleep which showed 
large variability between nights and within individuals.  The participants were more rested 
after the MHGI meal; these improvements were apparent in women only.  The postprandial 
glucose response tended to be larger after the MHGI meal compared to the MLGI meal (p = 
0.057) but there were no differences between insulin responses.  The postprandial TRP/LNAA 
levels were approximately 3.5 fold greater after the MHGI meal compared to the MLGI meal 
and marginally significant (p = 0.13), but did not result in a postprandial change in PPP-5HT. 
 
Discussion:  This study demonstrates significant clinical improvement in subjective sleep 
quality after a mixed macronutrient high GI meal despite marginal statistical significance.  The 
substantial variability in the night-to-night PSG data may have masked the influences of the 
meal response.  Given the present findings we suggest that there is a physiological threshold in 
the postprandial plasma TRP/LNAA concentration that must be surpassed in order to promote 
measurable changes to serotonin and sleep behaviour.  Future studies should elucidate more 
clearly the sex-differences underlying the impact of the GI on sleep behaviour.  
 
Keywords:  glycemic index, glycemic load, insomnia, tryptophan, serotonin 
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INTRODUCTION 
 
Globally, insomnia is the most common sleep complaints across all stages of adulthood 
(NIH 2005) and is characterised by subjective dissatisfaction with the quantity, quality, 
or timing of sleep that is present on most nights of the week for at least 1 month (Morin 
and Espie 2003).  Primary treatment for insomnia includes pharmacotherapy and 
cognitive behavioural therapy (CBT), however pharmaceuticals carry negative side 
effects (Ringdahl, Pereira et al. 2004) and CBT is associated with poor patient 
adherence (Ong, Kuo et al. 2008).  Sleep hygiene education is often included with 
behavioural interventions, but there is insufficient evidence to assess the effectiveness 
as a single therapy (Morgenthaler, Kramer et al. 2006).  One aim of sleep hygiene is to 
make patients more aware of how dietary practices may be either detrimental or 
beneficial for sleep.  
 
Complementary and alternative medicine therapies have long been popular with those 
battling insomnia, but have limited scientific support (Pearson, Johnson et al. 2006).  
Treatment with the pharmaceutical grade l-tryptophan is well established and 
demonstrates a dose-response effect in its clinical efficacy.  Remarkably, as little of 250 
mg of tryptophan improves sleep in people with chronic insomnia, while a 1000 mg 
dose is associated with more consistent results (Hartmann and Spinweber 1979).  On 
the other hand, the availability of dietary tryptophan (TRP) to the brain is dependent on 
its plasma concentration relative to other large neutral amino acids (TRP/LNAA) since 
each amino acid competes for a single transport molecule across the blood brain barrier 
(Wurtman 1988).  A high glycemic index (GI) meal results in a marked postprandial 
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rise in the concentration of TRP/LNAA with a peak between 3-4 h (Lyons and Truswell 
1988).  In a study involving participants with insomnia, provision of a bedtime snack 
containing a CHO (glucose) and dietary sourced TRP (pumpkin seeds) improved self-
reported (e.g., sleep diary) measures of sleep efficiency, total awake time after sleep 
onset, and sleep quality compared to a pre-treatment week (Hudson, Hudson et al. 
2005).  Recently, Afaghi et al. (2007) provided PSG data linking the GI to sleep 
initiation in healthy sleepers, but evidence is lacking regarding the effectiveness in 
persons with insomnia.  These authors reported a 50% reduction in the SOL after a high 
GI CHO rich compared to a low GI CHO rich meal given 4 h prior to sleep (Afaghi, 
O'Connor et al. 2007).  Although interesting, these studies do not provide sufficient 
guidance on the optimal and realistic meal composition needed to improve sleep.   
First, major differences in meal timing and the study population exist.  Second, neither 
study included the necessary biochemical measures to provide a mechanistic 
explanation for such sleep improvements.  Third, the findings of Afaghi et al. (2007) 
are limited in application given the high GI CHO rich meal was of considerably high 
glycemic load (GL) and therefore undesirable for regular use (Salmeron, Ascherio et al. 
1997). 
 
A dietary intervention resulting in a marked elevation of the postprandial plasma 
TRP/LNAA concentration potentially represents an accessible, cost-effective and low 
risk strategy for management insomnia but remains inadequately evaluated for this 
purpose.  Therefore, this study aimed to evaluate the efficacy of a high GI mixed 
macronutrient (MHGI) meal compared to an isoenergetic low GI mixed macronutrient 
(MLGI) meal consumed 3 h before bedtime to improve subjective and objective sleep 
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quality in insomnia.  In addition, the postprandial changes in the plasma TRP/LNAA 
concentration and serotonin production were assessed.   
The following a priori hypotheses were formulated based on the variance in GI and GL, 
since a greater release of insulin should follow the MHGI meal: (1) the MHGI meal 
will result in greater glycemic, insulin, and amino acid responses than the MLGI meal 
(2) the MHGI meal will result in greater subjective post-sleep improvements, and (3) 
the MHGI meal will result in improved objective sleep measures indicated by PSG 
(i.e., shorter SOL and improved sleep efficiency).  Sex differences will be explored 
where possible to elucidate the potential influence on the biochemical and sleep 
responses to the meals. 
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METHODS 
 
Participants 
Recruitment of participants with insomnia included flyers on university and community 
notice boards and a local newspaper advertisement.  Ethical approval (Appendix C) 
was received from the Human Research Ethics Committee of The University of Sydney 
and participants provided written informed consent prior to participation (Appendix E).  
Inclusion criteria defined suitable participants as men and women between 18-55 y.  An 
ability to attend overnight sleep studies on five occasions was also required and this 
limited the participant pool to residents living in the Sydney Metropolitan area.  
Personal interview and electronic mail was utilised to facilitate the administration of 
validated screening questionnaires to objectively determine the research diagnostic 
criteria (RDC) for primary insomnia following published guidelines (Edinger, Bonnet 
et al. 2004).   The Pittsburgh Sleep Quality Index (PSQI) was used to determine the 
previous one-month average sleep onset latency, its weekly occurrence, and to assess 
the overall sleep quality (Buysse, Reynolds et al. 1989).  The Insomnia Severity Index 
(ISI) was used to assess the level of weekly disturbance to SOL and the overall severity 
of insomnia symptoms (Bastien, Vallieres et al. 2001).  The final RDC for sleep 
initiation insomnia was indicated by a self-reported poor sleep quality (PSQI > 6), a 
minimum of sub clinical insomnia (ISI > 11), and an SOL of at least 30 min occurring 
at least three times per week for duration of at least one month.  Exclusion criteria 
included any current self-report of significant medical, psychiatric, or sleep disorders, 
food allergies, pregnancy, diabetes, or shift work (Appendix G). 
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Meals 
Two previously designed isoenergetic mixed macronutrient meals of known 
composition were either high GI (MHGI) or low GI (MLGI) (see Chapter 5).  Meals 
were consumed 3 h before individualised habitual bedtimes determined by a sleep 
diary.  The timing of the meals was chosen to match the suspected peak postprandial 
TRP/LNAA concentration.  Briefly, the MHGI meal provided 1916kJ (7.9g fat, 18.2 g 
protein, 75 g CHO) with GI (79) and GL (59) values.  The MLGI meal provided 1913 
kJ (7.9 g fat, 18.6 g protein, 75 g CHO) with GI (51) and GL (38).  The dietary amino 
acid contribution of TRP (determined from chicken and rice ingredients) was identical 
for each meal at approximately 168 mg (Harada, Hirotani et al. 2007).   
 
Study design and protocol 
The study was a randomised single blind cross-over trial.  The first night was 
designated a familiarisation period and data were not included in the subsequent 
analysis.  This was to minimise the first night effect (FNE; Chapter 4) and to screen for 
the presence of sleep disorders (e.g., obstructive sleep apnoea and periodic limb 
movements) characterised by >5 or >15 events per hour of sleep (Redline, Budhiraja et 
al. 2007).  Participants were randomly allocated to receive the MHGI and MLGI meals 
for two consecutive nights in a counterbalanced order.  A two night PSG period was 
needed to account for the extreme night-to-night variability in sleep quality that is 
present in those with insomnia (Vallieres, Ivers et al. 2005).  The period between sleep 
studies was variable (ranging from 0-28 days) to facilitate women participants being 
measured in the luteal phase of menstruation on each occasion.  This was to avoid a 
known disturbed sleep pattern during the follicular phase (Lee, Shaver et al. 1990).  
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Sleep variables from PSG were scored by an expert in sleep physiology (CMC) blinded 
to all conditions.  
 
On all occasions participants arrived to the research laboratory within 15 min of their 
scheduled meal time.  Participants were provided time to relax and were free to 
ambulate between the sleep laboratory, toilet, and research kitchen where a TV was 
made available.  Participants were monitored by the primary investigator and were not 
permitted to sleep prior to testing.   
 
Biochemical measurements (blood collections) were completed just prior to meal 
consumption (baseline) and at 60, 120, and 180 min intervals on the both testing night 
in each meal condition.  Due to budgetary constraints analysis was completed on the 
second night only.  The second night was chosen to minimise potentially unwanted 
daytime meal variability (Clark, Gardiner et al. 2006).  It was predicted participants 
would better adhere to the participant instructions on the second night.  Blood was 
collected from an indwelling cannula placed into a forearm vein that was removed just 
after the last collection.  The sampling line was kept patent using 0.9% saline in 
between collections.  A 2 mL sample was collected into a lithium heparin tube and 
immediately centrifuged at 2,500 g for 10 min at 4°C.   The supernatant was stored at -
80°C for determination of plasma amino acids by high phase liquid chromatography 
(HPLC, Shimadzu).  Analysis was completed in duplicate according to published 
guidelines (Huq, Thompson et al. 1993).   On a separate occasion, the sample was 
thawed and determination of blood glucose enzymatically using a Thermo Electron kid 
(Noble Park, Vic, Australia; cat no TR15103) and insulin using an Alpco ELISA kit 
(Alpco Diagnostics, Salem, NH, USA; cat no 80-INSHU-E01).  A separate 4 mL 
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sample was collected into an EDTA tube and immediately centrifuged at room 
temperature at 200 g for 10 min.  The resulting platelet rich plasma was spun at 4,500 g 
for 10 min.  The supernatant was stored at -80°C for determination of platelet poor 
plasma serotonin (PPP-5HT) using a commercially available enzyme immunoassay kit 
(IBL, Hamburg, Germany, RE59121).  It has been shown that food consumption 
influences PPP-5HT (Blum, Vered et al. 1992).  Moreover, PPP-5HT levels correlate 
well with changes in central serotonergic processes (Yan, Urano et al. 1993).  To 
compare glucose, insulin, and TRP/LNAA responses between meals the area under the 
curve (AUC) within the study period (180 min) was calculated according to published 
guidelines (Brouns, Bjorck et al. 2005).   
 
Subjective and PSG sleep measures 
Participants completed a  pre-sleep questionnaire (Appendix G) consisting of three 
individual 10cm visual analogue scales (VAS) used to assess subjective levels of 
postprandial satiety, sleepiness (both at baseline, 1, 2, and 3 h) and meal palatability 
immediately after the meal consumption only.  Anchor terms were as follows: satiety 0 
= still hungry, 10 = completely full; sleepiness 0 = completely awake, 10 = very sleepy; 
palatability 0 = poor taste, 10 = good taste).    
 
PSG sleep parameters were measured using a digital polygraph system (Compumedics 
W- or E-series, Compumedics Pty Ltd, Australia) with the following protocol: EEG 
(C4, 01, A1, A2), EOG (LOC, ROC), and EMG (masseter) according to published 
guidelines (Iber, Ancoli-Israel et al. 2007).  A grounding and reference electrode was 
placed at the Fpz and Pz position.  Electrodes were applied within the last half hour 
closest to bedtime at which point the participants were required to remain in the sleep 
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laboratory.  The following PSG variables were computed: sleep onset latency (SOL), 
total sleep time (TST), sleep efficiency (SE, time asleep/TST x 100), time awake after 
sleep onset (WASO), non-rapid eye movement sleep stage 1 (NREM1), stage 2 
(NREM2), stage 3 (NREM3), rapid eye movement sleep latency (REML), and REM 
sleep (REMS).  SOL was further defined as the first occurrence of any stage of sleep 
from lights off which was marked one minute after physiological calibrations.  PSG 
sleep variables were examined by an expert in sleep physiology (CMC) blinded to all 
conditions.   
 
Participants were permitted to sleep in self-selected body positions and could void in a 
nearby toilet if required.  The sleep environment was maintained between 21-23oC with 
complete darkness and free of windows.  Participants retired to bed ad libitum 
scheduling their desired sleep time to replicate habitual sleep practises. After 
awakening, sleep recording was ceased and the electrodes were removed.   
 
Participants completed a researcher designed post-sleep questionnaire (Appendix G) 
each morning after PSG testing to assess subjective sleep parameters similar to those 
obtained on the sleep diary, including SOL, number of nocturnal awakenings, WASO, 
and TST.  Participants were also asked to rate the quality of sleep compared to home on 
a five point Likert scale (much worse, worse, about the same, better, much better) and 
to describe the extent the sleep quality was perceived as (1) refreshing (2) restless (3) 
difficult to fall asleep and (4) how rested they feel this morning (not at all, somewhat, 
average, very, extremely).  A 10cm VAS scale was also used to assess a perceived 
feeling of sleepiness (0 = completely awake, 10 = very sleepy). 
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Participants were offered a standard breakfast (cereal and milk) before leaving the sleep 
laboratory.  Participants  were instructed prior to all test nights to maintain regular 
daytime routines but to refrain from napping, planned exercise (other than usual 
walking/commuting), alcohol, excessive caffeine (> 1 cup), and to remain nil by mouth 
(except water) within 3 h of the MHGI or MLGI dinner meal.  All subjects complied 
with experimental conditions to the extent of our questionnaires.  
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Statistical Analysis 
The sample size was calculated based on an effect size obtained for SOL (1.3) powered 
at 85% and alpha of 5% in a study comparing a high and low GI CHO meal given 4 h 
prior to sleep in healthy sleepers (Afaghi, O'Connor et al. 2007).  It was estimated that a 
modestly large effect size of 0.85 (Cohen 1988) and a calculated sample size of 15 
(Faul, Erdfelder et al. 2007) were appropriate to test the a priori hypotheses regarding 
meal differences. Data were tested for normality before statistical procedures were 
preformed using SPSS version 16 (SPSS Inc, Cary, NC, USA).  Data are reported 
means ± standard deviation (SD).  Data obtained for sleepiness, hunger, and palatability 
by VAS and subjective sleep measures were analysed by paired samples t-test to 
identify meal difference.  Paired samples t tests were also used to compare the averaged 
night 1 and night 2 PSG data between meals.  A repeated measures analysis of variance 
(ANOVA) was used to identify differences between individual night PSG data; within 
subjects factors were meal (MHGI or MLGI) and night (night 1 or night 2); gender was 
a between subjects factor.  A separate ANOVA with a priori contrasts was used to 
examine the postprandial meal effects on all biochemical measures; within subjects 
factors were meal (MHGI or MLGI) and time (0, 60, 120, 180 min).  In addition, a 
paired samples t-tests was used to identify differences between meals on the AUC data 
(glucose, insulin, and TRP/LNAA).  Independent samples t-tests were used to identify 
all gender differences.  Significance was met at p < 0.05 level. 
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RESULTS 
 
A total of 14 participants volunteered to take part in the study.  Three volunteers failed 
to complete the RDC questionnaires and 2 were unwilling to complete PSG procedures.  
One participant was excluded due to significant periodic limb movements.  A total of 8 
(4 men, 4 women) participants were randomised to the MHGI or MLGI meal and 
completed all dietary and PSG procedures.  Individual participant characteristics, ISI 
and PSQI scores, and the relative energy load (EL) of the test meals is summarised in 
Table 6.1.  The EL was calculated using an averaged energy value between the MHGI 
and MLGI meals (~ 1915 kJ) and individual participant BMI (kg.m
-2). 
 Mean EL of the 
test meals was significantly higher for women (32.0 ± 4.1 kJ.kg-1) than men (25.4 ± 3.7 
kJ.kg-1, p = 0.03).   The BMI (kg.m-2) was slightly higher for men (23.5 ± 2.1) than 
women (20.7 ± 0.96, p = 0.06).   
 
Table 6.1.  Participant characteristics, research criteria, and relative energetic load (EL) 
of the test meals in study participants 
 
Sex/Age 
 
BMI 
(kg.m
-2
) 
ISI 
 
PSQI 
 
EL 
(kJ.kg-
1
) 
M/32 22.9 11 9 28.2 
M/32 24.9 14 14 21.8 
M/31 25.4 28 17 22.5 
M/28 20.8 15 8 29.0 
F/20 22.2 11 9 27.0 
F/30 20.1 13 10 34.5 
F/39 20.7 23 16 36.1 
F/29 20.1 22 11 34.2 
M, male; F, female; BMI, body mass index. ISI, Insomnia Severity Index; PSQI, Pittsburgh 
Sleep Quality Index; EL, energy load.  Threshold scores for research diagnostic criteria for 
insomnia were ISI (>8) and PSQI (>6). 
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Meal palatability and subjective ratings of postprandial satiety and sleepiness 
Palatability ratings were similar on all study nights and were identical between the 
MHGI (7.7 ± 1.5 cm) and MLGI (7.8 ± 1.4 cm, p = 0.92) meals, indicating an overall 
good taste; there were no sex differences.  Subjective ratings of postprandial satiety 
were similar immediately after meal consumption (averaged data at baseline, MHGI: 
8.1 ± 1.5 cm; MLGI 7.6 ± 1.9 cm, p = 0.26) and throughout the study period, indicating 
participants were not overly hungry at bedtime (averaged data at 180 min, MHGI: 5.7 ± 
1.9 cm; MLGI: 5.3 ± 2.6 cm, p = 0.54).  Sex differences were present after the MLGI 
meal on the second night.  Women tended to report greater ratings for satiety 
immediately after meal consumption (women:  9.1 ± 1.3cm; men 7.9 ± 1.6 cm; p = 
0.06) and at bedtime (180 min, women: 7.4 ± 1.6 cm; men 4.1 ± 2.2 cm; p = 0.06).  
Subjective ratings on postprandial sleepiness indicated levels were similar on all study 
nights immediately after meal consumption (averaged data at baseline, MHGI: 3.2 ± 
1.6 cm; MLGI: 3.1 ± 1.9 cm; p = 0.69) and were greatest at bedtime (averaged data at 
180 min, MHGI 6.6 ± 1.9 cm; MLGI 6.2  ± 2.4 cm; p = 0.50), indicating sleepiness 
increased across the study period.  There were no differences between meals, nights, or 
across sexes.  
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Subjective post-sleep variables 
There were no significant differences in subjective post-sleep variables across nights 
therefore averaged data are presented.  Participants reported feeling more rested after 
the MHGI meal (2.8 ± 0.8 cm) than the MLGI meal (2.3 ± 0.9 cm; p = 0.01) on the 5-
point Likert scale corresponding to “average” and “somewhat”, respectively.  Women 
were more rested after the MHGI meal (3.0 ± 0.5 cm) than the MLGI meal (2.3 ± 1.0 
cm, p <0.05) meal but the ratings in men were not statistically different (MHGI: 2.6 ± 
1.1 cm; MLGI: 2.3 ± 0.9 cm; p = 0.20).  There were no other differences in subjective 
post-sleep variables.   
 
PSG sleep variables  
Table 6.2 summarises the effects of the meals on the sleep variables averaged across 
nights.  There were no significant differences in PSG sleep variables between meal 
conditions, however, there tended to be less EEG arousals (lower AI) after the MHGI 
compared to the MLGI meal (p = 0.06), however significant sex differences were 
present.  The AI difference between meals in women was statistically significant (p < 
0.05) but in men it was not (p = 0.60).  Overall, men had a higher AI than women after 
both the MHGI meal (p < 0.001) and the MLGI meal (p < 0.05).  Other marginal sex 
differences included the tendency for a shorter SOL in women compared to men after 
the MHGI meal (p = 0.06).  There was a tendency in men to have more light sleep 
(NREM1) after the MLGI meal compared to the MHGI meal (p = 0.07) but no 
differences observed in women (p = 0.75).  SWS tended to be greater in females after 
the MLGI meal compared to the MHGI meal (p = 0.06) but no differences were 
observed in men (p = 0.24).   
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Table 6.2.  Effects of the MHGI and MLGI meals on averaged PSG sleep variables in 
participants with insomnia 
PSG variable MHGI MLGI Meal difference 
SOL (min) 28.3 ± 19.2 28.1 ± 18.1  
Men 37.3 ± 17.6
b
 33.6 ± 16.2  
Women 19.4 ± 17.3 24.3 ± 19.8  
REML (min) 99.9 ± 42.5 103.7 ± 36.2  
Men 107.0 ± 46.3 102.3 ± 32.2  
Women 92.8 ± 40.0 104.6 ± 41.9  
SE (%) 86.8 ± 7.5 88.2 ± 5.6  
Men 84.2 ± 7.0 86.4 ± 6.0  
Women 89.4 ± 7.4 89.9 ± 4.9  
TST (min) 452.9 ± 45 473.2 ± 50.2 p = 0.09 
Men 441.8 ± 44.9 470.7 ± 52.5  
Women 464.1 ± 45.1 475.6 ± 51.3  
WASO (min) 40.6 ± 31.6 36.0 ± 29.8  
Men 44.9 ± 31.3 40.0 ± 34.9  
Women 36.3 ± 33.3 31.9 ± 25.4  
NREM1 (%) 2.4 ± 1.1 2.7 ± 1.5  
Men 2.5 ± 0.8 3.2 ± 1.6 p = 0.07 
Women 2.3 ± 1.3  2.3 ± 1.3  
NREM2 (%) 52.3 ± 7.7 50.4 ± 7  
Men 51.2 ± 9.5 50.4 ± 8.7  
Women 53.5 ± 5.7 50.4 ± 5.4  
SWS (%) 20.0 ± 42 20.6 ± 4.4  
Men 20.9 ± 4.6 18.9 ± 5.2  
Women 19.1 ± 3.8 22.2 ± 2.9 p = 0.06 
NREMS (%) 74.8 ± 5.0 73.7 ± 5.9  
Men 74.6 ± 5.6 72.6 ± 5.3  
Women 74.9 ± 4.4 74.9 ± 6.5  
REMS (%) 25.3 ± 4.9 26.3 ± 5.9  
Men 25.5 ± 5.6 27.4 ± 5.3  
Women 25.1 ± 4.4 25.1 ± 6.6  
AI (no./h) 8.1 ± 2.7 9.2 ± 3.1 p = 0.06 
Men 8.1 ± 2.7a 9.2 ± 3.1a  
Women 6.0 ± 1.2 7.7 ± 2.0 p < 0.01 
Values are mean ± sd .  
Bold values represent entire sample (n = 8), non-bold for each sex (4 men, 4 women)  
Comparison between sexes; a (p < 0.05) or b (p ≤ 0.10) 
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Table 6.3 summarises the effects of the meals on the sleep variables over both nights.  
There was a trend for a shorter SOL on the first compared to the second night after both 
the MHGI and the MLGI meals for all participants (bolded value; F, night, (1,6) = 5.6, 
p = 0.06).  Figure 6.1 shows the objective PSG values compared to the post-sleep 
subjective ratings for SOL on individual nights after the MHGI and MLGI meals. 
Women tended to have a shorter SOL on each night compared to men but these 
differences were not statistically significant.  There was a delayed REML on the first 
compared to the second night for both men and women, but this was differential by 
meal and sex (F, meal x night x sex (1,6) = 6.3, p = 0.05).  Women had a delayed 
REML on the first compared to the second night after the MHGI meal whereas REML 
in men was delayed after the MLGI across nights; however these differences were not 
statistically significant (in women: p = 0.16; in men; p = 0.41).  Light sleep (NREM1) 
tended to be greater on the first compared to the second night in women but not men (F, 
night by sex (1,6) = 5.1, p = 0.06) in whom no differences were observed between 
meals (MHGI: p = 0.26; MLGI: p = 0.14).  In men, SWS on night 1 was greater than 
night 2 after the MHGI meal but was similar in women (F, night x sex (1,6) = 6.8, p = 
0.04).  Men had a similar AI on each night and these were significantly higher than for 
women (F, meal x night x sex (1,6) = 9.5, p = 0.02).  Women had a greater AI on the 
first night compared to the second night after the MLGI (p < 0.05). 
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Table 6.3.  Effects of the MHGI and MLGI meals on individual night PSG sleep 
variables in participants with insomnia  
Sleep variables 
MHGI 
Night 1 
MHGI 
Night 2 
MLGI  
Night 1 
MLGI 
Night 2 
SOL (min) 24 ± 15.3
#
 32.7 ± 22.6 22.7 ± 18
#
 35.2 ± 17 
Men 30.3 ± 14.9 44.2 ± 19.3 27.0 ± 17.9 40.1 ± 13.3 
Women 17.8 ± 14.5 21.1 ± 21.6 18.3 ± 19.6 30.3 ± 20.9 
REML (min) 111.4 ± 49.3 88.3 ± 33.6 108.2 ± 34.9 99.1 ± 39.2 
Men 107.1 ± 57.9 106.9 ± 40.7 115.6 ±26.7 89.9 ± 35.6 
Women 115.8 ± 47.6 69.8 ± 7.2 100.8 ± 44.4 108.3 ± 45.7 
SE (%) 86.5 ± 8.9 87.2 ± 6.3 89.8 ± 5.3 86.5 ± 5.7 
Men 85.2 ± 8.7 83.3 ± 6.0 88.8 ± 4.7 84.1 ± 6.8 
Women 87.8 ± 10.2 91.1 ± 4.0 90.8 ± 6.4 89.0 ± 3.5 
TST (min) 448.6 ± 48.8 457.3 ± 43.7 480.6 ± 46.7 465.8 ± 55.6 
Men 448.5 ± 50.8 435.0 ± 44.7 482.4 ± 55.1 459.0 ± 55.0 
Women 448.8 ± 54.6 479.5 ± 45.2 478.8 ± 45.2 472.5 ± 63.7 
WASO (min) 45.9 ± 43.0 35.3 ± 14.8 34 ± 23.9 37.9 ± 36.2 
Men 47.1 ± 45.6 42.6 ± 14.3 33.6 ± 23.5 46.4 ± 46.6 
Women 44.8 ± 47.3 27.9 ± 12.7 34.4 ± 27.8 29.5 ± 26.7 
NREM1 (%) 2.5 ± 1.3 2.3 ± 0.8 2.9 ± 1.4 2.5 ± 1.7 
Men 2.4 ± 0.99 2.6 ± 0.78 3.1 ± 1.7  3.3 ± 1.7 
Women 2.7 ± 1.7 2.1 ±0.92 2.8 ± 1.2 1.8 ± 1.4 
NREM2 (%) 51.4 ± 7.2 53.3 ± 8.4 51.0 ± 7.7 50.0 ± 6.7 
Men 49.3 ± 9.1 53.1 ± 10.9 51.6 ± 10.1 49.3 ± 8.6 
Women 53.5 ± 5.4 53.5 ± 6.9 50.4 ± 6.0 50.5 ± 5.6 
SWS (%) 21.3 ± 4.3 18.7 ± 3.9 20.8 ± 5.4 20.3 ± 3.5 
Men 23.6 ± 3.8* 18.2 ± 3.9 19.7 ± 7.3 18.1 ± 2.5 
Women 19.0 ± 3.7 19.1 ± 4.4 21.9 ± 3.2 22.5 ± 3.1 
NREMS (%) 75.2 ± 4.2 74.3 ± 5.8 74.8 ± 5.3 72.7 ± 6.7 
Men 75.3 ± 4.8 74.0 ± 7.0 74.4 ± 3.1 70.7 ± 6.9 
Women 75.1 ± 4.1 74.7 ± 5.4 75.1 ± 7.7 74.7 ± 6.6 
REMS (%) 24.9 ± 4.1 25.7 ± 5.8 25.3 ± 5.3 27.3 ± 6.64 
Men 25.0 ± 4.8 26.1 ± 7.0 25.6 ±3.1 29.3 ± 6.9 
Women 24.9 ± 4.0 25.4 ± 5.4 25.0 ± 7.5 25.3 ± 6.7 
AI (no. h
-1
) 8.3 ± 3.1 8.0 ± 2.4 9.2 ± 3.1 9.2 ± 3.4 
Men 10.7 ± 2.2 a 9.9 ± 1.5 a 10.3 ± 3.6 a 11.3 ± 3.6 a 
Women 5.9 ± 1.5  6.0 ± 1.1  8.1 ± 2.6*  7.2 ± 1.6 
Values are mean ± sd  
Bold values represent entire sample (n=8), non-bold for each sex (4 men, 4 women)  
Comparison between nights; * (p < 0.05) or # (p ≤ 0.10); between sexes; a (p < 0.05) or b (p ≤ 
0.10) 
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Figure 6.1.  Effects of the MHGI and MLGI meals on objective and subjective sleep 
onset latency (SOL) in participants with insomnia.  The PSG SOL was shorter on the 
first night compared to the second in each meal condition (p = 0.056).  The PSG 
values were lower than subjective ratings.  Abbreviations: PSG, polysomnography; 
MHGI, mixed macronutrient high GI; MLGI, mixed macronutrient low GI; SR, 
subjective rating. 
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Postprandial change in biochemical measures  
The postprandial glucose and insulin responses are shown in Figure 6.2 (n = 6, 3 men, 
3 women); two participants were not willing to complete the procedure.  The glucose 
response (AUC) tended to be greater after the MGHI meal (179.0 ± 115.0) compared to 
the MLGI meal (71.3 ± 66.4, p = 0.06).  There was no significant difference in the 
postprandial rise in insulin levels between meals (MHGI: 1536.3 ± 1574.2; MLGI: 
1529.3 ± 1515.3). 
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Figure 6.2.  Postprandial glucose and insulin responses after the MHGI and MLGI meals in 
participants with insomnia.  The glucose response (AUC) tended to be greater after the MHGI 
meal compared to the MLGI meal (p = 0.06) but the insulin responses were not statistically 
different. MHGI, mixed macronutrient high GI; MLGI, mixed macronutrient low GI. 
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The postprandial TRP/LNAA response is shown in Figure 6.3 (n = 4, 1 man, 3 
women); two participants were unwilling to undergo the procedure.  Both meals 
elicited a significant postprandial change (time; F (3,9) = 8.8, p < 0.01), however there 
was a brief decline at 60 min followed by an increase to 180 min.  The maximum 
percentage rise from baseline occurred at 3 h postprandially after the MHGI (17%) and 
the MLGI meals (8%, both p < 0.05).  The AUC after the MHGI (1.73 ± 1.3) was 
approximately 3.5-fold greater than after the MLGI meal (0.50 ± 0.5) and this 
difference was marginally significant (paired t-test, p = 0.13).  Table 6.4 indicates the 
postprandial plasma TRP/LNAA concentrations.    
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Figure 6.3.  Effects of the MHGI and MLGI meals on the postprandial TRP/LNAA levels in 
participants with insomnia.  The TRP/LNAA levels were maximal at bedtime (3 h 
postprandially) reaching a peak percentage rise from baseline after the MHGI (17%) and 
MLGI (8%).  The area under the curve (AUC) after the MHGI meal was nearly 3.5-fold higher 
than the MLGI meal but this was not statistically significant (paired samples t-test, p = 0.06).  
Abbreviations: MHGI, mixed macronutrient high GI; MLGI, mixed macronutrient low GI. 
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Table 6.4.  Mean TRP/LNAA concentration after the MHGI and MLGI meals in 
participants with insomnia 
Time MHGI (mmol/L) MLGI (mmol/L) 
0, baseline 0.1023 ± 0.012 0.1098 ± 0.015 
60 min 0.1011 ± 0.022 0.1045 ± 0.016 
120 min 0.1148 ± 0.028 0.1117 ± 0.008 
180 min 0.1200 ± 0.017 0.1117 ± 0.012 
Values are mean ± sd.  MHGI; mixed macronutrient high GI; MLGI, mixed 
macronutrient low GI 
 
Platelet Poor Plasma Serotonin (PPP-5HT) 
There was no significant postprandial change in PPP-5HT concentrations (n = 4, 1 
man, 3 women); data were erroneous for four participants due to platelet contamination 
(Yan 1993).  The levels were similar between meals at all time points: baseline MHGI 
(8.7 ± 1.7 ng.ml-1) and MLGI (8.8 ± 1.8 ng.ml-1); 60 min HGI (9.3 ± 1.5 ng.ml-1) and 
MLGI (8.9 ±1.3 ng.ml-1); 120 min MHGI (8.3 ±1.7 ng.ml-1) and LGI (8.2 ±1.0 ng.ml-1); 
and 180 min MHGI (7.7 ±1.8 ng.ml
-1
) and MLGI (8.6 ± 0.9 ng.ml
-1
). 
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DISCUSSION 
 
To our knowledge this is the first study to compare the effects of a high and low GI 
mixed macronutrient meal on subjective and PSG sleep in participants meeting RDC 
for insomnia.  The primary aim was to demonstrate empirical efficacy for the MHGI 
meal to improve sleep onset and sleep efficiency.  In addition, the influence of the GI of 
mixed macronutrient meals on postprandial TRP/LNAA and PPP-5HT concentrations 
were investigated to explore the possible mechanisms underpinning observed sleep 
changes.  The pre-sleep ratings for meal palatability, satiety, and postprandial 
sleepiness confirm the MHGI and MLGI meals are suitable for use as an evening meal 
and represent a practical, cost-effective strategy to study the effects of the GI and GL 
on sleep.  Subjective sleep improvement was present after the MHGI meal and this was 
especially apparent for women.  Overall, there were no differences in the averaged PSG 
sleep data between meals, however women showed relative improvements (i.e., shorter 
SOL) compared to men.  The individual night PSG sleep data demonstrated significant 
variability among all participants.  Evidence to support the mechanisms underlying 
improvements to sleep after the MHGI meal were limited to the postprandial increase 
in TRP/LNAA given there were no changes in postprandial PPP-5HT levels.   
 
The MHGI and MLGI were designed to deliver approximately 1915 kJ (~ 457 kCal), 
but to vary in their glycemic responses.  The meals were provided as an evening meal 
and served at 3 h prior to individual habitual bedtimes.  The participants rated both 
meals similarly indicating both were highly palatable and favoured a good taste.  
Subjective ratings for satiety immediately after meal consumption were similar in both 
meals and across nights.  As would be expected, postprandial satiety declined and 
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reached lowest levels at bedtime (3 h), but no single rating was below a score of 
approximately 4 cm on the 10-cm VAS.  These findings indicate the meals provided 
sufficient energy to the participants and extreme hunger was clearly obviated up to 
bedtime.  To the extent of the study questionnaires, only two subjects (both men) 
provided anecdotal evidence for perceived hunger.  Indeed, the energetic load (kJ/kg) 
was significantly greater in women compared to men indicating the MHGI and MLGI 
meal size was larger for women.  It is likely this difference contributed to the subjective 
sleep improvements in women only.   
 
Post-sleep assessment of sleep quality indicated women, but not men reported a more 
restful sleep after the MHGI meal.  This sex-different is consistent with published data.  
In response to a high CHO, low fat meal given throughout the working day, women 
tended to report greater postprandial sleepiness than men (Wells and Read 1996; Wells, 
Read et al. 1998).   Moreover, in women, a decline in alertness is prominent for those 
eating larger sized-meals compared with a more habitual sized lunch meals (Smith, 
Ralph et al. 1991).  Unfortunately, the measurement of satiety by VAS may not have 
been sufficiently sensitive to detect meaningful changes to hunger.  In men, brain 
imaging data show greater activation in the prefrontal cortex and paralimbic areas in 
response to hunger that may be perceived as greater anxiety and stress (Del Parigi, 
Chen et al. 2002).  Increased cortical activation is known to perpetuate disturbed sleep 
quality (Vgontzas, Bixler et al. 2001).  Indeed, the post-sleep assessment of WASO was 
not remarkable between meals.  Thus, the subjective sleep measurements alone were 
not sensitive to detect the effects of hunger during the sleep period.   
 
 - 122 - 
The average PSG data after the MHGI also did not indicate significant sleep 
improvement however sex differences were apparent corroborating the subjective sleep 
improvements after the MHGI meal in women but not men.  There was a strong 
tendency in women to have a shorter SOL for after the MHGI meal (19.4 min) 
compared to men (37.3 min).  Further, women, but not men, had a shorter SOL after the 
MHGI meal compared to the MLGI meal (24.3 min) but this difference was not 
statistically significant.  On the other hand, men experienced a poor sleep quality after 
both the MHGI and MLGI meals.  This was characterised by a prolonged SOL, reduced 
sleep efficiency, increased WASO, more light sleep (NREM1), and more sleep 
fragmentation (AI) compared to women (Table 6.2).  A recent meta-analysis reports a 
clear female predominance for insomnia however the factors (Zhang and Wing 2006).    
Nearly 55% of insomniacs report having recent psychosocial stressor (Specchio, 
Prudenzano et al. 2004).  Unfortunately, we did not formally assess anxiety or mood 
states.  Also, the period between studies was variable, especially between men and 
women.  Thus, a possible explanation for the present findings may be related to 
differences in underlying psychopathology.  In addition, the individual night PSG data 
demonstrate significant night-to-night variability, especially among values for SOL and 
REML (Table 6.3).  The SOL for most participants was shorter on the first night 
compared to the second night in each meal condition.  The data in both sexes (bolded 
value) on REML show a tendency for a delayed REML on the first night compared to 
the second, but this response was variable in men and women (Table 6.3).  It has 
known that variability in sleep pattern is a characteristic inherent of insomnia 
(Vallieres, Ivers et al. 2005).    Indeed, using a single PSG study may miss the bigger 
picture of the insomnia complaint (Edinger, Marsh et al. 1991).   Thus, different data 
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sets may have been reported had we not conducted sleep studies on two consecutive 
nights.  
 
Noteworthy, is the measurement of both subjective and PSG sleep as it affords 
important clinical inference.  Figure 6.1 shows the PSG SOL values on individual 
nights in comparison to subjective SOL values.  The PSG values were considerably 
lower than the subjective ratings for SOL on each study night.  Further, the self-
reported SOL after the MHGI meal shows a decline from night 1 to night 2 and 
therefore does not follow with PSG values.  These findings demonstrate contrasting 
subjective and objective measures of sleep and are consistent with the presence of 
psychophysiological insomnia (Perlis, Giles et al. 1997).  A greater cortical activation 
has been observed in patients with psychophysiological insomnia compared to good 
sleepers (Bastien, St-Jean et al. 2008).  Thus, the meal effects would have been further 
masked by difficulty initiating normal sleep processes.  
 
The biochemical responses observed after the MHGI and MLGI meals provide 
reasonable evidence for a high GI meal to promote sleep quality despite a small sample 
size.  There was a significantly greater postprandial glucose response after the MHGI 
meal compared to the MLGI meal but insulin release was not different between meals 
(Figure 6.2).  The postprandial TRP/LNAA level peaked at bedtime (3 h 
postprandially) for both meals (Figure 6.3).  The AUC data further indicate 
TRP/LNAAA levels after the MHGI meal were approximately 3.5-fold higher than the 
MLGI meal although this difference was only marginally significant.  The magnitude of 
the percentage increase in plasma TRP/LNAA after the MHGI meal (17%) was nearly 
identical to a previous study using the same meals in healthy volunteers after an 
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overnight fast (Chapter 5).  In addition, the previous study demonstrated a greater 
TRP/LNAA response after a high GI CHO (CHGI) meal which has previously been 
shown to improve SOL in compared to an isoenergetic low GI CHO meal in healthy 
sleepers (Afaghi et al. 2007).  Whilst the TRP/LNAA response after the CHGI meal 
(23%) was only marginally higher than the MHGI meal, this meal did not improve 
sleep initiation in participants with insomnia.  These findings raise several factors 
regarding the efficacy of the MHGI meal to improve sleep.  First, the GL of the MHGI 
meal was not sufficiently high to elicit a postprandial TRP/LNAA level similar to the 
CHGI meal (Chapter 5).  We may speculate that the relative increase after the CHGI 
meal reflects a maximum physiological response to typical mixed macronutrient meals.  
Thus, it is likely that a specific physiological threshold may exist that corresponds to a 
sufficient TRP/LNAA level that would promote 5HT production and measurable 
changes in sleep behaviour.  Theoretically, this physiological threshold may have been 
surpassed in women given the greater energetic load, however the present study was 
underpowered to appropriately identify this sex-specific response and we therefore 
caution over generalisation.  Moreover, the study populations were different between 
these studies.  Thus, it remains largely unknown whether such a threshold would be 
similar for both healthy and poor sleepers.  
 
Despite the study limitations previous discussed it should also be noted that control for 
daytime meals may be warranted as it is known the synthesis and release of 
neurotransmitters are influenced by their nutrient precursors (Wurtman, Hefti et al. 
1981).  Second, postprandial 5HT concentration may have been further influenced by 
poor pharmacokinetics of ingested dietary TRP.  Provision of vitamin B3 and B6 may 
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increase the conversion rate of TRP to 5HT and meet dietary requirements (Young 
1991).  
 
In summary, subjective sleep was improved after a high GI compared to an isoenergetic 
low GI mixed macronutrient evening meal provided 3 hr prior to the usual bedtime.  
Given the sleep period inherent to insomnia demonstrates clear night-to-night 
variability, a long-term prospective dietary intervention using validated subjective sleep 
measures represents a cost-effective strategy to further test the efficacy for regular 
consumption of a high GI mixed macronutrient meal to improve sleep quality. 
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CHAPTER 7 – Conclusions 
 
Sleep propensity increases with progression of the day.  At dark onset the release of 
melatonin increases sleep pressure culminating in a rapid sleep onset in regular 
sleepers.  The transition between sleep-wake states reflects complex activity in many 
neuronal regions.  For those with insomnia, heightened psychophysiological process 
deters sleep despite a high propensity.  The relationship between the GI and sleep lies 
in the insulin-mediated availability of the amino acid tryptophan relative to other large 
neutral amino acids (TRP/LNAA), where available TRP is readily converted into 
serotonin (5HT).  Recently, Afaghi et al (2007) showed that a high GI CHO rich meal 
given 4 h before bedtime shortens the sleep onset latency (SOL) compared to an 
isoenergetic low GI meal in healthy sleepers.  These findings form the basis of this 
thesis.   
 
The primary aim of this thesis was to evaluate the efficacy of a high GI mixed 
macronutrient (MHGI) meal to improve sleep quality compared to an isoenergetic low 
GI mixed macronutrient (MLGI) meal.  Sleep quality was measured in the laboratory 
using subjective and PSG measures in participants with insomnia.  In addition, 
biochemical analysis was performed to measure the postprandial TRP/LNAA and 5HT 
concentrations.  The new findings from this thesis can be encapsulated as follows: (1) a 
meta-analysis confirms the first night effect (FNE) in healthy sleepers and provides an 
estimate for the observed changes in 9 PSG sleep variables across the first two 
consecutively recorded nights; (2) the postprandial plasma TRP/LNAA concentration 
demonstrates a dose-response to the glycemic load (GL) of a meal; (3) the postprandial 
TRP/LNAA response to the mixed macronutrient meal was identical in healthy 
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individuals (Chapter 5) and participants with insomnia (Chapter 6); and (4) preliminary 
findings show that the MHGI meal improved subjective sleep quality, especially in 
women. 
 
The findings from Chapter 4 provide novel advancement to aid in PSG study designs. 
This study provided the first quantitative review of the FNE in 24 studies involving 421 
healthy subjects over 4 decades.  Notably, there was poor clinical homogeneity in 
studies involving participants with insomnia and depression.  Therefore, a qualitative 
review was provided.  It was determined that the final study (Chapter 6) should perform 
PSG recordings on 2 consecutive nights under each meal condition.   
 
The presented work in Chapters 5 provides valuable biochemical data to support the 
underlying mechanisms promoting sleep initiation after high GI meals.  Notably, this 
study demonstrated the postprandial change in TRP/LNAA concentration was not 
proportional to the GI but instead is likely mediated by the GL.  The TRP/LNAA 
response was 3.5 fold greater after the MHGI meal compared to the MLGI meal but 
both were attenuated compared to the carbohydrate only high GI (CHGI) meal.  This 
CHGI meal was replicated from the study from Afaghi et al (2007).  Given the CHGI 
meal provided substantial energy (kJ) and a large CHO load (~ 140 g) compared to the 
mixed macronutrient meals, it is likely the TRP/LNAA response after the CHGI meal 
reflects a maximum physiological response.  Further, the TRP/LNAA response after the 
MHGI meal was only marginally reduced compared to the CHGI meal (Chapter 5).  
Thus, this study provided sufficient indication that the MHGI meal may promote sleep 
onset similar to the CHGI meal.   
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The therapeutic impact of a high GI mixed macronutrient meal to improve sleep onset 
was marginal.  The findings in Chapter 6 indicate the MHGI meal improves subjective 
sleep quality when provided as a regular evening meal 3 h prior to bedtime but only to 
women with insomnia.  Remarkably, the postprandial increase in plasma TRP/LNAA 
concentration after the mixed macronutrient meal was identical in healthy participants 
(Chapter 5) and in the participants with insomnia (Chapter 6).  However, despite an 
elevated TRP/LNAA response, especially after the MHGI meal, platelet poor plasma 
(PPP) 5HT concentration remained unchanged.  Further studies are required to evaluate 
a GL dose-response on 5HT concentration in order to confirm the mechanisms 
underlying improved sleep after high GI meals.   
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Comparison to previous findings 
The MHGI and MLGI meals were provided as an evening meal replacement at 3 h prior 
to individualised habitual bedtimes.  This was done to match the measured peak 
postprandial TRP/LNAA level (Chapter 5).  The only other study to measure 
TRP/LNAA levels in the evening was the study by Lyons & Truswell (1998).  In this 
study, the increase in TRP/LNAA concentration was nearly identical when 
carbohydrate meals were provided after an overnight fast and in the evening between 
1800 and 1830 h (Lyons and Truswell 1988).  Whilst the present results mimic this 
previous finding, there may be underlying circadian modulation of the individual 
glucose and insulin responses.   
 
The diurnal cortisol rhythm may mediate the diurnal variation in carbohydrate tolerance 
(Van Cauter, Shapiro et al. 1992).  Under experimental conditions, the postprandial 
glucose response measured after a mixed meal (43% CHO) was greater in the evening 
rather in the morning, yet this was not associated with a commensurate insulin 
secretion (Van Cauter, Shapiro et al. 1992).  In addition, this meal (500 kCal) was 
provided at 2000 h and ‘light out’ was performed using a fixed scheduled at 2300 h, 
which is nearly identical with respect to the meal size and meal timing in the present 
study.  Circadian changes such as low cortisol levels in the evening are associated with 
increased insulin sensitivity (Van Cauter, Shapiro et al. 1992).  In the present studies 
we did not measure cortisol levels and therefore its relationship to insulin sensitivity 
remains unknown.  Further, the biological consequences of experimental sleep loss in 
healthy participants cannot be applied to primary insomnia (Riemann, Klein et al. 
2002).  However, it is likely the incoherence among the glucose and insulin responses 
among the insomnia population presented in Chapter 6 is due to elevated cortisol 
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secretion (Riemann, Kloepfer et al. 2009)and disturbed endocrine function (Buckley 
and Schatzberg 2005)  Indeed, in the present study (Chapter 6) there was a postprandial 
decline in insulin just after meal consumption in three participants.  
 
Further study on the relationship between circadian rhythmicity (cortisol), feeding 
behaviour, and the metabolic responses leading to increased availability of TRP is 
needed, especially in primary insomnia.  These findings could provide future evidence 
for dietary intake to be used as a therapy for other abnormal circadian rhythm disorders 
such as jet-lag and shift work.   
 
Another difference in meal timing exists between the current study and that of Afaghi 
et al. (2007) in which the CHO high GI meal was provided both at 4 h and 1 h prior to 
bedtime.  In their study, the CHO high GI meal (replicated here as CHGI) resulted in a 
significant reduction to SOL both at 1 h and 4 h compared to a low GI CHO meal given 
at 4 h prior to bedtime only.  Unfortunately, we did not measure 5HT levels after the 
CHGI meal in the current project.  In the rat, levels of 5HT and its metabolite, 5-
hydroxyindolacetic acid (5-HIAA), increase as soon as the beginning of meal 
consumption (Orosco and Nicolaidis 1992).  However, 5HT function in humans may 
also be measured indirectly through changes in melatonin concentration since 5HT is 
the intermediary product to melatonin (Zimmermann, McDougle et al. 1993).  
Remarkably, Afaghi et al. (2007) reported the evening collection of urinary 6-
hydroxymelatonin (6-SM), a metabolite of melatonin, showed no significant difference 
between the CHGI meal at 4 h, the CHGI meal at 1h or the low GI CHO meal at 1 h 
before bedtime (Afaghi, O'Connor et al. 2007).  At least in the animal model, only 
carbohydrate ingestion, which stimulates pancreatic insulin secretion and not protein or 
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fat mobilisation, could reliably account for both synthesis and release of hypothalamic 
5HT (Orosco and Gerozissis 2001).  Thus, these findings together indicate that 
additional evidence is needed to elucidate whether the relative improvements to sleep 
after a high GI meal are indeed mediated solely by increased 5HT pathways.   
 
Alternative hypothesis 
Support for the hypothesis of a direct central mechanism leading to postprandial 
sleepiness after CHO ingestion exists.  Activity in the hypothalamus involving the 
hypocretin-orexin system (orexins) may act as a “gate” to allow sleep or increase 
mutually exclusive behaviour, such as feeding (Burdakov, Alexopoulos et al. 2005).  
Orexins are a specialised group of glucose sensing neurons (GSN) that exhibit specific 
inhibitory and excitatory activity depending on extracellular levels of glucose in the 
brain.  In the animal model, low extracellular glucose levels act to inhibit GSN 
containing orexins, thereby resulting in increased locomotion and food-seeking 
behaviour.  Alternatively, high extracellular glucose levels promote excitation of GSN 
containing melanin-concentrating hormone, resulting in increased sleepiness.  Basal 
levels in the hypothalamus appear to be about 1.4 mmol/L in the rat brain (de Vries, 
Arseneau et al. 2003).  Generally, extracellular concentrations of glucose in the brain 
are 10-30% lower than levels in the blood (Routh 2002; de Vries, Arseneau et al. 2003; 
Levin, Routh et al. 2004).  Importantly, brain glucose concentration follows closely to 
changes in the plasma (Silver and Erecinska 1994).  Given typical meal to meal 
fluctuations in blood glucose are between 4-8 mmol/L, this corresponds to levels in the 
brain at approximately 1 and 2.5 mmol/L which may result in a physiological stimulus 
for sleep (Burdakov, Luckman et al. 2005).  Remarkably, the findings presented in this 
thesis support this proposed mechanism.   
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First, it was reported that postprandial sleepiness measured during the day occurred as 
early as 30-60 min after ingestion of CHO compared to baseline conditions (Wells, 
Read et al. 1997; Wells, Read et al. 1998).  Indeed, Afaghi et al. (2007) also reported a 
shorter SOL in healthy sleepers after the high GI CHO meal (CHGI) given 1 h before 
bedtime compared to the low GI CHO meal given 4 h before bedtime.  Remarkably, the 
corresponding blood glucose level after the CHGI meal (9 mmol/L, Chapter 5) was 
nearly identical to the level originally reported (Afaghi, O'Connor et al. 2007).  
Theoretically, the corresponding blood glucose levels in the brain after the CHGI meal 
between 0.9 – 2.7 mmol/L, may have been sufficient to stimulate central GSN activity 
thereby promoting sleep, especially between 30 – 60 min when peak glucose occurred.  
Moreover, the peak glucose response of the CHGI meal was significantly higher than 
the MHGI meal, both in healthy participants (~7.8 mmol/L, Chapter 5) and in 
participants with insomnia (~6.5 mmol/L, Chapter 6).  Thus, if the central mechanism 
is validated, it would appear the MHGI meal did not provide the necessary postprandial 
glucose response sufficient to change sleep behaviour, especially in the final study.  
Consistent with our previous suggestion, it appears that the GL of mixed meals may be 
a useful marker to predict the acute glucose and insulin response and therefore 
postprandial sleepiness.   
 
In consideration of the alternative hypothesis suggesting a direct central mechanism for 
the relative sleep improvements after CHO ingestion, a high GI snack eaten at 
approximately 45 min to 1 h prior to bedtime may be a more useful strategy to improve 
sleep quality.  This type of intervention could be delivered in a small energetic load and 
therefore would obviate potential weight gain or other negative metabolic effects of 
regular consumption of high GL evening meals.   
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Limitations of the project 
Several factors contributed to a low statistical power in the experimental chapters.  
First, Chapter 5 used a venepuncture procedure for blood collection thus limiting the 
data as participants were unwilling to undergo the procedure.  The blood collection 
procedure was change in Chapter 6 and an indwelling cannula was used.  Unfortunately 
5HT data were lost due to platelet contamination as PPP 5HT sample preparation is 
considerably difficult (Maria, Ribeiro et al. 2004).  Second, both experimental studies 
were repeated measures studies involving six days (Chapter 5), however, this time 
requirement cannot be avoided by GI testing.  Further, the final study course was five 
nights (Chapter6) and participant payment was minimal due to financial constraints.  In 
addition, the PSG procedure in the final study period was appropriate in view of the 
findings from the meta-analysis of the FNE (Chapter 4).  Thus, despite recruitment of 
14 mixed-gender participants, the final participant group consisted of only eight 
persons and was mixed 50% by gender.  Given the present findings future studies 
should aim to exploit the interaction between meal size and the sex-differences among 
the efficacy of the mixed macronutrient high GI meal to improve sleep quality. 
 
A separate methodological concern relates to the recruitment of participants with 
insomnia in the final study.  Despite each participant meeting the research diagnostic 
criteria for insomnia, the participants were not matched for difficulties in maintaining 
sleep.  Further, the threshold ISI was arbitrarily chosen.  A more rigorous RDC for 
insomnia is needed in view of the clinical heterogeneity of the participants.  It can be 
noted here that part of the a priori hypothesis was in fact a lower glycemic response of 
the MHGI compared to the CHGI meal.  Thus, a group of healthy sleepers was not 
tested given there is little room for sleep improvement (Bonnet and Arand 2003).   
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Directions for further research 
Further studies are needed to expose the relationship between the GI and GL of mixed 
macronutrient meals and sleep quality.  A dietary intervention using similar meals 
varying in GI or GL would provide data to substantiate a dose-response effect on 
factors included in this thesis; notable the postprandial TRP/LNAA response, 5HT 
synthesis and/or release, and sleep improvements.   
 
The screening questionnaire used for participant recruitment also provided detail on the 
habitual meal timing.  These data indicate, at least for some participants, the MHGI and 
MLGI meals were provided closer to bedtime than the usual evening meal.  Indeed, 
food acts as a zeitgeber in humans for circadian rhythmicity (Krauchi, Cajochen et al. 
2002).  Thus, a long-term study is needed to evaluate the efficacy of a high GI or high 
GL meal as an evening meal replacement, especially in participants with insomnia who 
demonstrate significant night-to-night variability in sleep quality.  A minimum of a 1 or 
2 weeks would be necessary to overcome the conditioned and maladaptive behaviours 
contributing to this reduced quality of sleep.   
 
Finally, it is likely PSG studies in the laboratory are not required to evaluate treatment 
efficacy in primary insomnia.  Instead, actigraphy and/or sleep diaries could be 
employed as these are both valid and reliable forms of assessment of insomnia (Morin 
2004) and for other circadian rhythm disorders (Buysse, Ancoli-Israel et al. 2006). 
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